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ABSTRACT 
Regulation of Cytoplasmic Dynein via Local Synthesis of its Cofactors, Lis1 and p150
Glued
 
Joseph Manuel Villarin 
 
Within the past thirty years, the discovery and characterization of the microtubule-
associated motor proteins, kinesins and cytoplasmic dynein, has radically expanded our 
understanding of intracellular trafficking and motile phenomena. Nevertheless, the mechanisms 
by which eukaryotic cells integrate motor functionality and cargo interactions over multiple 
subcellular domains in a spatiotemporally controlled way remain largely mysterious. 
During transport within the neuronal axon, dynein and the kinesins run in opposite 
directions along uniformly polarized microtubule tracks, so that each motor must switch between 
active transport and being, itself, a cargo in order to be properly positioned and carry out its 
function. The axon thus represents a model system in which to study the regulatory mechanisms 
governing intracellular transport, especially under conditions when it must be modulated in 
response to changing environmental cues, such as during axon outgrowth and development. 
Recently, the localization of certain messenger RNAs and their local translation to yield 
protein has emerged as a critical process for the development of axons and other neuronal 
compartments. I observed that transcripts encoding the dynein cofactors Lis1 and dynactin are 
among those localized to axons, so I hypothesized that stimulus-dependent changes in axonal 
transport may occur via local synthesis of dynein cofactors. In these studies, I have shown that 
different conditions of nerve growth factor signaling on developing axons trigger acute changes 
in the transport of various axonal cargoes, contemporaneous with rapid translational activation 
and production of Lis1 and dynactin’s main subunit, p150
Glued
, within the axons themselves. 
Differential synthesis of these cofactors in axons was confirmed to be required for the observed 
stimulus-dependent transport changes, which were completely prevented by axon-specific 
pharmacologic inhibition of protein synthesis or RNA interference targeted against Lis1 and 
p150
Glued
. In fact, Lis1 was, in an apparent paradox, locally synthesized in response to both nerve 
growth factor stimulation and withdrawal. I demonstrated that this is due to the fact that Lis1 is 
produced from a heterogeneous population of localized transcripts, differentiated chiefly by 
whether they interact with the RNA-binding protein APC. Preventing the binding of APC to Lis1 
transcripts thus inhibited axonal synthesis of Lis1 and its resultant transport effects under 
conditions of nerve growth factor stimulation, while having no bearing on the similar phenomena 
seen during nerve growth factor withdrawal. This demonstrates that association with RNA-
binding proteins can functionally distinguish sub-populations of localized messenger RNAs, 
which, in turn, provides a foundation for mechanistically understanding how localized protein 
synthesis is coupled to specific stimuli. 
Axonally synthesized Lis1 also was shown to have a particular role in mediating 
transport of a retrograde death signal originating in nerve growth factor-deprived axons, as 
neurons exhibited greatly reduced cell death when axonal synthesis of Lis1 was blocked. 
Through the application of pharmacologic agents inhibiting different steps in the propagation of 
this pro-apoptotic signal, I established that the signal depends upon effective endocytosis and the 
activity of glycogen synthase kinase 3β. It is therefore likely that the retrogradely transported 
signaling cargo in question is a glycogen synthase kinase 3β-containing endosome or 
multivesicular body—a type of large cargo consistent with Lis1’s known role in adapting the 
dynein motor for high-load transport. Preliminary results further indicate that axons exposed to 
another type of degenerative stress, in the form of toxic amyloid-β oligomers, may also employ 
local synthesis of Lis1 as a means of regulating transport and survival signaling. 
These findings establish a previously undescribed mechanism of regulating dynein 
activity and cargo interactions through local synthesis of its cofactors, allowing for rapid 
responses to environmental cues and stimuli that are especially relevant during the development 
of the nervous system. In addition to illustrating a regulatory principle that may be generally 
applicable to subcellular compartments throughout polarized cells, these studies provide new 
insights into intracellular transport disruptions that occur in lissencephaly, neurodegeneration, 
and other human disease states. 
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CHAPTER I. GENERAL INTRODUCTION 
 
The earliest report of motile phenomena in living cells dates to the pioneering 
microscopic studies of van Leeuwenhoek, but the first mechanistic explanations for the observed 
movements within cells came only in the 19th century. Wilhelm Kühne, coiner of the term 
"enzyme," broke new ground by linking the contraction of muscle cells to the function of a 
protein, identified as myosin (Kühne 1859, Kühne 1864). That myosins are themselves enzymes, 
utilizing ATP to power their movement relative to an actin scaffold, would gradually become 
clear a century later (Engelhardt and Ljubimowa 1939, Banga and Szent-Györgyi 1942, Huxley 
and Niedergerke 1954, Huxley and Hanson 1954). With these discoveries, the notion of a 
molecular motor was born. 
By the mid-1950s, George O. Gey and his colleagues could leverage the resources of 
ultrastructural and time-lapse microscopy to assemble the most vivid picture to-date of the living, 
dynamic cell, including its remarkable "endocellular traffic" (Gey, Shapras et al. 1954). Palade 
would go on to show the importance of vesicular trafficking for the secretory pathway of protein 
synthesis, tying cell biology into the advancement of the molecular biology revolution (Caro and 
Palade 1964). However, the nature of this intracellular transport would remain very poorly 
understood until several studies established the existence of the cytoskeleton, an intracellular 
network with actin, tubulin, and other polymeric components, common to many types of 
eukaryotic cell (Inoue and Sato 1967, Ishikawa, Bischoff et al. 1969). 
A veritable explosion of new data followed on the heels of this seminal work: the 
characterization of new motor proteins, pharmacological inhibitors, and regulatory pathways 
acting upon the cytoskeleton. Yet, despite our greater insights into the molecular basis of 
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transport, many questions remain unresolved at the point of convergence between the cellular 
motors, their cargoes, and the cytoskeletal substrate. For instance, how does the cell coordinate 
the participation of all these players into an intracellular transport regime that is, at once, locally 
adaptable and coherent as a whole? Recent advances in RNA and protein biology, beyond the 
ken of Crick, Palade, or their contemporaries, challenge much of our received wisdom and 
furnish new paradigms to explain these nuanced aspects of cellular physiology. 
 In this introductory chapter, a focused overview will be provided on three topics of 
interest to contemporary biological research: the intracellular transport system, localization of 
messenger RNA and its translation, and positive and negative factors in the neurochemical 
milieu. Individually, these subjects could each brook exhaustive analysis that might fill, at the 
very least, the space allotted for this entire chapter. However, the most relevant aspects for 
comprehension will necessarily be emphasized, as well as those areas where these topics 
potentially intersect or inform one another. The later chapters, hopefully, will succeed in 
demonstrating how these facets of cellular life are, in fact, intimately linked, taking into account 
new evidence presented here for the first time. 
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I.1. Molecular Mechanisms of Intracellular Transport 
 In evolving beyond the size and relative simplicity of prokaryotes, eukaryotic cells had to 
overcome a fundamental biophysical problem: how to maintain the rate of certain vital chemical 
reactions when the enzymes and reactants involved had ever-greater space in which to diffuse 
away from each other. One solution was the origin of internal membranes, which enclose smaller 
spaces, within vesicles and organelles, where the necessary elements for a given reaction can be 
brought into close proximity and kept away from other cellular contents. Another, associated 
endeavor was the further development of the prokaryotic cell’s rudimentary polymeric scaffolds 
and force-generating enzymes into a system of active transport that would facilitate the spatial 
orientation and interaction of macromolecules as well as the new membranous organelles. 
Research continues into the structural basis of this transport system and the host of proteins that 
enable its work, but its centrality to eukaryotic cellular functioning is already evident. 
 
a. Microtubule-based motors: dyneins and kinesins 
 Besides the aforementioned myosins, which were eventually shown to be a family of 
ubiquitous actin-based motors not restricted only to muscle cells (Pollard and Korn 1973, Pollard 
and Korn 1973, Hammer, Jung et al. 1986), the other motor proteins responsible for transport in 
eukaryotic cells—dyneins and kinesins—associate with microtubules. Structurally, a microtubule 
is a hollow cylinder measuring 24 nanometers in its outer diameter, whose wall is formed by a 
sheet of protofilaments assembled from heterodimeric complexes of α- and β-tubulin as building 
blocks (Gibbons 1961, Shelanski and Taylor 1968, Feit, Slusarek et al. 1971). The consistent 
orientation of heterodimers within protofilaments gives microtubules an inherent polarity (Amos 
and Klug 1974). For cytosolic microtubules, minus-ends are generally associated with a 
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microtubule organizing center near the nucleus, which, in animal cells, is an organelle called the 
centrosome (Gould and Borisy 1977). Plus-ends, meanwhile, are characterized by “dynamic 
instability,” meaning that they tend to exist in either a shrinking phase or a growing phase 
protected from disassembly by a cap of GTP-bound tubulin (Mitchison and Kirschner 1984). 
In addition to their differing structures and genetic lineages, the two superfamilies of 
microtubule motors are functionally distinguished by which microtubule end they tend to be 
directed toward. Dyneins are the principal group of minus-end directed motors. The first 
representative of this motor family to be discovered was axonemal dynein, which is not involved 
in transport but, instead, produces the beating of cilia and flagella (Gibbons and Rowe 1965). 
Two cytoplasmic dyneins were subsequently identified: cytoplasmic dynein 1 is the general 
motor for transporting minus-end directed cargo in cells (Paschal, Shpetner et al. 1987, Schnapp 
and Reese 1989), whereas cytoplasmic dynein 2 is specific to intraflagellar transport (Gibbons, 
Asai et al. 1994, Pazour, Dickert et al. 1999). The cytoplasmic dynein holoenzyme is a 
dimerized, multisubunit complex, with each monomer containing one heavy chain bearing the 
ATPase force-generating and microtubule-binding domains, one intermediate chain (~74 kDa), 
two light intermediate chains (~53-59 kDa), and several distinct light chains [FIGURE 1-A] 
(Neely, Erickson et al. 1990, Holzbaur and Vallee 1994, Hughes, Vaughan et al. 1995). The 
intermediate chains form a focal platform for integrating dynein’s binding with the various light 
chains and other regulatory cofactors (Susalka, Nikulina et al. 2002), which, interestingly, appear 
to distinguish functional subfractions of cytoplasmic dynein through combinatorial complexity 
(Tai, Chuang et al. 2001). Reductively, however, the processive movement of cytoplasmic 
dynein along microtubules requires only dimerization of the two heavy chains, whose 
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microtubule-binding stalks shuffle past each other in rather uneven steps that appear to be 
significantly influenced by diffusion (Reck-Peterson, Yildiz et al. 2006). 
The kinesins, which facilitate plus-end directed transport, stand in contradistinction to 
many of the described qualities of the dynein motor. To begin with, it is worth noting that, while 
there is only one cytoplasmic dynein in non-ciliated cells, myriad different kinesin-related 
proteins have been found in eukaryotes (Endow and Hatsumi 1991), some of which are even 
minus-end directed (Walker, Salmon et al. 1990). Conventional kinesins in metazoans form 
dimers of two identical heavy chains each bound to a light chain (Vale, Reese et al. 1985), but 
other kinesin family members function as heterotrimers (Cole, Chinn et al. 1993), homodimers 
without light chains (Seiler, Kirchner et al. 2000, Setou, Nakagawa et al. 2000), or monomers 
(Nangaku, Sato-Yoshitake et al. 1994, Okada, Yamazaki et al. 1995). Association with different 
kinesin light chain isoforms is thought to mediate selective interactions with different types of 
cargo or even modulate the motility characteristics of individual motors (Rahman, Friedman et 
al. 1998). Mechanistically, kinesins are consistent motors that hydrolyze one ATP molecule to 
take one step (Schnitzer and Block 1997) of discrete, 8 nanometer size (Svoboda, Schmidt et al. 
1993), without attempts at lateral stepping (Gelles, Schnapp et al. 1988). 
Before continuing to discuss dynein and kinesins more specifically in the context of 
transporting macromolecules and membrane-bound cellular structures, it must be mentioned that 
these motors have a variety of other roles in the life of the cell. Aside from well-characterized 
involvement in assembling the mitotic spindle (Hagan and Yanagida 1990, Merdes, Ramyar et 
al. 1996), cytoplasmic dynein and kinesins have also emerged as organizers of the cytoskeleton 
in non-dividing cells. Both microtubule motors are essential for the assembly and maintenance of 
intermediate filament networks containing vimentin (Gyoeva and Gelfand 1991, Helfand, 
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Mikami et al. 2002) or neurofilaments (Yabe, Pimenta et al. 1999, Shah, Flanagan et al. 2000). 
Combined with evidence that these motors interact with actin (Kuriyama, Gustus et al. 2002, 
Rehberg, Kleylein-Sohn et al. 2005, Meiri, Marshall et al. 2012) and can even regulate 
nucleation of their own microtubule tracks at the centrosome (Young, Dictenberg et al. 2000), it 
becomes clear that dynein and kinesins help to coordinate the actin, tubulin, and intermediate 
filament components of the cytoskeleton in a manner which should not be overlooked. 
 
b. Motor cofactors and regulatory interactions 
At this point, the question arises as to how a single type of cytoplasmic dynein can 
effectively perform for minus-end directed transport the plenitude of functions associated with 
all the various kinesins in plus-end directed transport. In point of fact, cytoplasmic dynein is not 
truly alone, as it is subject to regulation by signal transduction pathways as well as a multitude of 
cofactors that adapt the motor's functionality to its specific task at hand. Of these cofactors, two 
of the most essential and best-characterized are dynactin and Lis1. 
Dynactin is a large complex of 11 protein subunits with a combined molecular mass 
rivaling that of dynein itself [FIGURE 1-A] (Schroer 2004). In vitro, dynactin was shown to be 
necessary for dynein-mediated vesicle translocation (Gill, Schroer et al. 1991), and it is believed 
to be required, in one way or another, for virtually all of dynein’s functions in vivo (Karki and 
Holzbaur 1999). The largest and primary functional subunit of dynactin is the DCTN1 gene 
product p150
Glued
 (Holzbaur, Hammarback et al. 1991), which has domains that bind dynein 
intermediate chain (Karki and Holzbaur 1995), microtubules, and another dynactin subunit, Arp1 
(Waterman-Storer, Karki et al. 1995). Within each dynactin complex, an octameric polymer of 





 and p50/dynamitin (Echeverri, Paschal et al. 1996); a pointed-end complex consisting 
of Arp11, p62, p27, and p25 (Eckley, Gill et al. 1999); the actin-capping protein CapZ and a 
conventional β-actin monomer (Schafer, Gill et al. 1994). The Arp1 rod also seems to mediate 
dynactin’s interaction with many membranous cargoes by binding directly to spectrin-family 
proteins found on the surface of certain vesicles and organelles (Holleran, Ligon et al. 2001, 
Muresan, Stankewich et al. 2001). Dynactin’s smallest subunit, p24/p22, is closely associated 
with the flexible, extensible “arm,” formed by p150
Glued
 and p50/dynamitin, which projects out 
of the Arp1 rod (Karki, LaMonte et al. 1998). Given its interactions with both dynein and 
microtubules, the dynactin complex is generally understood to improve the processivity of the 
motor by enhancing its attachment to microtubule tracks, thereby increasing average run length 
(King and Schroer 2000, Ross, Wallace et al. 2006). On the other hand, it has been argued that 
dynactin’s microtubule binding is important principally in the initiation step of dynein-based 
transport, a function which is separable from its enhancement of motor processivity. While this 
explains the observation that mutations in the microtubule-binding domain of p150
Glued
 reduce 
minus-end directed vesicular flux without altering the transport characteristics of moving cargoes 
(Kardon, Reck-Peterson et al. 2009, Moughamian and Holzbaur 2012), it only makes the 
mechanism behind dynactin’s influence on motor processivity that much more mysterious. 
Encoded in humans by the gene PAFAH1B1, platelet-activating factor acetylhydrolase IB 
subunit alpha—also known as Lis1—is a ubiquitously expressed protein, albeit most prominent 
in the brain, heart, and skeletal muscle (Reiner, Carrozzo et al. 1993). Disruption of Lis1 
function is the etiology of classic lissencephaly and Miller-Dieker syndrome (Dobyns, Reiner et 
al. 1993, Lo Nigro, Chong et al. 1997), due to the failure of neuronal precursors to migrate along 
radial glia and populate the layers of the cerebral cortex (Feng, Olson et al. 2000). It was first 
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identified through genetic screens of mutants with perturbed dynein-dependent positioning of the 
nucleus (Xiang, Beckwith et al. 1994), also characteristic of its binding partners NudE (Minke, 
Lee et al. 1999, Efimov and Morris 2000) and NudEL (Niethammer, Smith et al. 2000, Sweeney, 
Prokscha et al. 2001). The NudE homologues are considered to be enhancers of Lis1’s 
interaction with dynein (Li, Lee et al. 2005), as overexpression of Lis1 has been seen to rescue 
the effects of NudE and NudEL loss of function (Markus, Punch et al. 2009). Curiously, in 
addition to Lis1-NudE/NudEL binding to dynein intermediate chain and LC8, one of the light 
chain subunits (Stehman, Chen et al. 2007), Lis1 is also the only cofactor currently known to 
interact directly with the dynein heavy chain (Sasaki, Shionoya et al. 2000, Mesngon, Tarricone 
et al. 2006). Due to apparent contacts at both the ATPase and microtubule-binding domains, Lis1 
has been proposed to act as a molecular “clutch” (Huang, Roberts et al. 2012), inducing moving 
dynein to remain in a force-producing, microtubule-attached state (McKenney, Vershinin et al. 
2010). At the ensemble level, Lis1 thus appears to help dynein crews withstand high-load 
transport, such as during nuclear migration (Tanaka, Serneo et al. 2004) or when moving other 
large structures through a constrained environment with high drag forces (Yi, Ori-McKenney et 
al. 2011). Nevertheless, as with dynactin, alternative models of Lis1 function have been put 
forward stressing its role as a potential “initiation factor” for dynein-mediated transport. 
According to evidence from lower eukaryotes, without Lis1 dynein accumulates at microtubule 
plus-ends (Zhang, Li et al. 2003), even though Lis1 is absent from and has no effect on the 
motility of dynein-cargo complexes that are already in motion (Egan, Tan et al. 2012). Given the 
seeming conflict between these findings and those from metazoans supporting the idea of Lis1 as 
a high-load motor adaptor, Lis1’s part in dynein transport initiation remains controversial. 
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Additional dynein regulators include CLIP-170, whose principal function does, in fact, 
seem to lie in facilitating dynein transport initiation at microtubule plus-ends (Carvalho, Gupta Jr 
et al. 2004, Lomakin, Semenova et al. 2009), and the Bicaudal D homologues, which are 
metazoan-specific cargo adaptors especially important for linking dynein to mRNA (Swan, 
Nguyen et al. 1999, Bullock and Ish-Horowicz 2001) and Golgi vesicles (Hoogenraad, 
Akhmanova et al. 2001, Matanis, Akhmanova et al. 2002). Another set of proteins only found in 
metazoans, Spindly and the Rod-Zwilch-ZW10 complex, work together in recruiting dynein and 
its cofactors to the kinetochore (Starr, Williams et al. 1998, Williams, Li et al. 2003, Griffis, 
Stuurman et al. 2007) in order to remove mitotic checkpoint inhibition (Howell, McEwen et al. 
2001) and effect chromosome separation (Sharp, Rogers et al. 2000). 
Many of the dynein regulatory proteins have notable interactions with each other, which 
can be cooperative or competitive. Direct binding between Lis1 and CLIP-170 has been detected, 
and the two appear to jointly regulate dynein motor complex function at kinetochores and other 
microtubule plus-ends (Coquelle, Caspi et al. 2002, Tai, Dujardin et al. 2002). Outside of 
mitosis, ZW10’s participation in dynein-mediated Golgi membrane trafficking is thought to 
involve its interaction with dynactin’s p50/dynamitin subunit (Hirose, Arasaki et al. 2004, 
Varma, Dujardin et al. 2006). Bicaudal D2, dynactin, and Lis1 have all been reported to 
cooperate in recruiting dynein to certain vesicular cargoes for transport (Splinter, Razafsky et al. 
2012), although other studies indicate that dynactin and Lis1-NudE/NudEL antagonize each 
other by competing for binding sites on CLIP-170 (Lansbergen, Komarova et al. 2004) and 
cytoplasmic dynein’s own intermediate chain [FIGURE 1-A] (McKenney, Weil et al. 2011). By 
excluding the possibility of dynein’s simultaneous regulation by both dynactin and Lis1, it is 
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proposed that the dynein motor can be shifted between different modes of transport specialized 
for diverse cellular tasks—e.g. processive, long-distance versus high-load, multi-motor transport. 
Like cytoplasmic dynein, some kinesins have also been shown to undergo regulation by 
motor cofactors. According to a recent study, the microtubule-associated protein ensconsin helps 
to relieve autoinhibition of kinesin-1 and is thus an essential cofactor enabling the motor to 
undertake its primary function of organelle transport (Barlan, Lu et al. 2013). Furthermore, 
several dynein cofactors, including Lis1 and dynactin, are known to interact with kinesins. 
During plus-end targeting of dynein, Lis1 serves as an adaptor linking dynein, as a cargo, to the 
active kinesin motor (Li, Lee et al. 2005, Yamada, Toba et al. 2008). Meanwhile, dynactin’s 
p150
Glued
 subunit associates with kinesin-5 (Blangy, Arnaud et al. 1997) and kinesin-2, the latter 
of which it assists by linking it to some types of organelles and enhancing its processivity 
(Deacon, Serpinskaya et al. 2003, Berezuk and Schroer 2007). Indeed, interfering with kinesin 
function has long been known to disrupt transport in either direction along microtubules (Brady, 
Pfister et al. 1990), and the near-identical effects of dynactin inhibition suggest that it supplies a 
critical regulatory link between kinesin and dynein motors (Waterman-Storer, Karki et al. 1997). 
As in many physiological systems, another major regulatory approach to controlling 
intracellular transport is through post-translational modification, particularly by protein kinases. 
Phosphorylated kinesins bind vesicular cargoes less efficiently (Sato-Yoshitake, Yorifuji et al. 
1992) and may be impaired at transporting higher loads (DeBerg, Blehm et al. 2013). Direct 
phosphorylation of dynein heavy chain correlates with increased motor activity in metazoan cells 
(Dillman and Pfister 1994, Lin, Ferro et al. 1994), though in vitro data and studies in lower 
eukaryotes have suggested that phosphorylation of various dynein subunits generally diminishes 
its ATPase activity (Runnegar, Wei et al. 1999, Kumar, Lee et al. 2000). Such an effect might be 
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attributable to suppression of the complete assembly of the dynein motor complex, since 
phosphorylation of dynein light chains promotes their dissociation from the holoenzyme (Song, 
Benison et al. 2007) and phosphorylation of the intermediate chain interferes with its binding of 
dynactin (Vaughan, Leszyk et al. 2001) or Lis1-NudE/NudEL (Gao, Hebbar et al. 2015). During 
mitosis, intermediate chain phosphorylation has even been proposed as a switch determining 
whether dynein associates with ZW10 or dynactin, thereby regulating dynein’s initial targeting to 
kinetochores and subsequent detachment (Whyte, Bader et al. 2008). Dynein cofactors, too, are 
themselves subject to phosphoregulation, as has been demonstrated with NudEL (Sasaki, 
Shionoya et al. 2000) and dynactin’s p150
Glued
 subunit (Farshori and Holzbaur 1997). 
The fact that various characteristics of the microtubule motors can be adjusted via 
covalent modification and association with different cofactors offers a glimmer of insight into 
how the cell might coordinate motor activity, both systematically and within its subcellular 
compartments. In cell types with many such differentiated compartments, such as neurons, the 
regulation of intracellular transport is beset by a number of unique challenges. Yet despite—or, 
really, because of—their complexity, neurons have proven to be an exemplary model system in 
which to study intracellular transport, enabling us to better understand how the regulatory 
principles already discussed impact the lives of cells and entire organisms. 
 
c. Axoplasmic transport and other microtubule motor functions in neurons 
Essentially all types of eukaryotic cells feature morphological polarity, i.e. the 
differentiation of structurally and functionally distinct regions within the cell. In neurons, the 
fundamental distinction is between the soma, or cell body, and neurites, which are cytoplasm-
containing projections arising from the soma. Neurites are subdivided into dendrites and axons. 
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Dendrites are highly branched, generally tapering extensions possessing a cytoplasm continuous 
with that of the soma (Deiters 1865, Luse 1956), through which, as Ramón y Cajal understood, 
neurons often receive many of their synaptic inputs (Ramón y Cajal 1899). A single nerve cell 
can have a ramification of many dendrites, although some kinds have none at all. In contrast, 
only one neurite per cell is distinguished as the axon, usually forming the longest process, of 
more or less uniform diameter over its entire course, without extensive branching. Action 
potentials, the electrochemical units of information output in the nervous system, propagate 
along axons after being initiated in the axon initial segment (Edwards and Ottoson 1958), which 
also comprises a barrier separating the somatic membranes and cytoplasm from those of the axon 
[FIGURE 1-A] (Kobayashi, Storrie et al. 1992, Winckler, Forscher et al. 1999, Song, Wang et 
al. 2009). 
In terms of their internal structure, one of the most striking features of axons is that 
virtually all of their microtubules are oriented in a uniform direction, with their minus-ends 
proximal and plus-ends distal to the soma (Heidemann, Landers et al. 1981). Dendrites, 
meanwhile, possess mixed-polarity microtubules in roughly equal proportions for much of their 
length, although their most distal segments do display uniform polarity similar to axons (Baas, 
Deitch et al. 1988, Burton 1988). Curiously, when a neuron’s projections are just beginning to 
grow and develop, before one is differentiated to become the axon, they all, in fact, contain 
uniformly polarized microtubules (Baas, Black et al. 1989). Another way of framing the 
difference between dendrites and the axon, therefore, is to say that dendrites acquire mixed 
microtubule polarity as they mature, whereas the axon is basically the one projection that 
maintains its initial uniform orientation of microtubules. Moreover, consistent with what has 
been mentioned previously regarding the motor proteins as regulators of cytoskeletal structure, it 
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is known that these processes of neurite development and differentiation require the activity of 
kinesins and cytoplasmic dynein. Several of these motors localize specifically to the neurite that 
will become the axon; if their localization or function is inhibited, this neurite loses uniform 
microtubule polarity like all the others, and no axon develops (Nishimura, Kato et al. 2004, 
Jacobson, Schnapp et al. 2006, Zheng, Wildonger et al. 2008). At the migrating, amoeboid tip of 
a developing axon, the growth cone, dynein is also required to power microtubule advance in the 
face of an opposing flow of actin. This process, during which dynein must partner specifically 
with Lis1, is essential for the directional turning and stimulated outgrowth of axons, thus 
enabling them to reach their target fields and establish the connectivity of whole nervous system 
(Myers, Tint et al. 2006, Grabham, Seale et al. 2007). 
The unidirectional activity of each family of microtubule motors, combined with the 
uniform orientation of axonal microtubules, immediately suggests how they might be applied to 
axoplasmic transport. Indeed, as would be expected, the transport of membrane-bound structures 
in the anterograde direction—that is, away from the cell body, or towards plus-ends—is 
undertaken by kinesins (Vale, Reese et al. 1985, Vale, Schnapp et al. 1985), while retrograde 
transport utilizes cytoplasmic dynein (Schnapp and Reese 1989). Anterograde and retrograde 
transport of membrane-bound structures take place at roughly the same rate, on the order of 
hundreds of millimeters per day (Ochs, Sabri et al. 1969, Forman, Padjen et al. 1977). Though 
there is some overlap between the kinds of membranous cargo moving in either direction, the 
anterograde and retrograde transport pools are by no means identical. Retrogradely moving 
cargoes tend to be endocytic in nature, ranging from pinocytic vesicles to large lysosomes and 
multivesicular bodies, while anterograde transport principally involves smooth endoplasmic 
reticulum and other small vesicular and tubular structures, such as synaptic and plasma 
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membrane precursor vesicles (Smith 1980, Tsukita and Ishikawa 1980, Hollenbeck 1993). 
Mitochondria, on the other hand, are transported in both directions (Zelena 1968), as are some 
non-membranous cellular components, such as proteins (Bray and Austin 1968, Fink and Gainer 
1980) and mRNA granules (Li, Volknandt et al. 1999). 
Not all cellular components transported into the axon, however, move at the same pace. 
The axon’s own cytoskeletal polymers, including microtubules, neurofilaments, and actin 
filaments (Grafstein, McEwen et al. 1970, Hoffman and Lasek 1975, Black and Lasek 1979), as 
well as some apparently soluble metabolic enzymes (Erickson and Moore 1980, Brady and Lasek 
1981) move much more slowly in the anterograde direction than membrane-bound structures, 
reaching maximum velocities of less than 20 millimeters per day (Willard, Cowan et al. 1974, 
Willard and Hulebak 1977). The trafficking of tRNAs into axons appears to proceed at a 
similarly slow rate (Ingoglia, Grafstein et al. 1973, Black and Lasek 1977). Juxtaposed with the 
“fast anterograde transport” of vesicles and organelles, this enigmatic mechanism has been 
dubbed, simply, “slow transport,” and it remains the subject of considerable debate and 
speculation even after many years of research. Only recently has a rough consensus emerged 
affirming the participation of the microtubule motors in slow transport, with what has been 
termed the “stop-and-go” model being the predominant explanation at present. According to this 
model, slow transport components are actually moved by microtubule motors, but their coupling 
to the transport machinery is intermittent and highly inefficient in comparison to that of 
membranous cargoes (Miller and Heidemann 2008). This hypothesis is bolstered by experiments 
showing that cytoskeletal polymers in axons undergo rare but rapid bidirectional movements, 
consistent with the velocities of kinesins and dynein, interspersed between long pauses (Roy, 
Coffee et al. 2000). 
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As described previously, the transport behaviors of the microtubule motors can be 
regulated by signal transduction cascades, and mounting evidence suggests that one particular 
phosphorylation pathway is of critical importance to the coordination of axonal transport. CDK5 
is a protein kinase that is strongly localized to axons (Tsai, Takahashi et al. 1993). One of its 
phosphorylation targets is the dynein cofactor and Lis1 binding partner NudEL. Since 
overexpression of dominant-negative CDK5 or an unphosphorylatable mutant of NudEL strongly 
inhibits retrograde transport of organelles, it has been argued that CDK5 phosphorylation of 
NudEL stimulates Lis1-NudEL’s interaction with dynein (Pandey and Smith 2011). On the other 
hand, CDK5 also phosphorylates GSK3 in axons, inactivating it. Because active GSK3’s 
phosphorylation of kinesin light chains causes kinesin to dissociate from cargo, CDK5 therefore 
enhances kinesin-based transport as well (Morfini, Szebenyi et al. 2004), establishing CDK5 and 
its downstream effectors as major regulators of both anterograde and retrograde transport. 
 
d. Transport dysfunction in human disease 
Experiments of nature provide us with copious examples of the consequences that follow 
from failure of the intracellular transport machinery or its regulatory mechanisms. Besides Lis1 
haploinsufficiency resulting in the devastating neurodevelopmental disorder of lissencephaly, 
genetic abnormalities in the kinesins, cytoplasmic dynein, and their cofactors produce several 
other neurodegenerative diseases. Defects in the kinesin family members KIF5A and KIF1A 
cause hereditary spastic paraplegias (Reid, Kloos et al. 2002, Erlich, Edvardson et al. 2011), and 
KIF1B mutation is responsible for Charcot-Marie-Tooth disease type 2A (Zhao, Takita et al. 
2001). Each of these motors is involved in axoplasmic transport of various essential cargoes, 
including synaptic vesicle precursors (Okada, Yamazaki et al. 1995), mitochondria (Nangaku, 
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Sato-Yoshitake et al. 1994, Karle, Mockel et al. 2012), and neurofilaments (Xia, Roberts et al. 
2003). Meanwhile, mutations at the DCTN1 locus, encoding p150
Glued
, cause distal spinal and 
bulbar muscular atrophy HMN7B (Puls, Jonnakuty et al. 2003), the early-onset parkinsonism of 
Perry syndrome (Farrer, Hulihan et al. 2009), as well as some cases of familial ALS (Munch, 
Sedlmeier et al. 2004). Recent work has also linked mutations in DYNC1H1, a dynein heavy 
chain gene, to a number of familial neurological disorders: Charcot-Marie-Tooth disease type 2O 
(Weedon, Hastings et al. 2011), distal spinal muscular atrophy with lower extremity 
predominance (Harms, Ori-McKenney et al. 2012), and a form of hereditary mental retardation 
(Vissers, de Ligt et al. 2010). 
Even neurological disorders that do not have simple, monogenic causes directly affecting 
the motor proteins often feature obvious dysfunctions in intracellular transport, which may 
contribute to disease progression. In models of Huntington’s disease, mutant huntingtin protein 
has been seen to aggregate in axons, interrupting transport and causing axonal degeneration that 
conspicuously precedes the disease’s hallmark neuronal loss (Li, Li et al. 2001, Szebenyi, 
Morfini et al. 2003). Likewise, axoplasmic transport disruption is considered to be one of the 
earliest abnormalities detectable in transgenic models of ALS (Williamson and Cleveland 1999) 
and Alzheimer’s disease (Ishihara, Hong et al. 1999, Stokin, Lillo et al. 2005). Regarding the 
latter disease, in particular, one of its most prominent pathologic characteristics is aggregation of 
the microtubule-associated protein tau, which might directly inhibit transport (Ebneth, 
Godemann et al. 1998) or lead to transport dysfunction by destabilizing the cytoskeleton 
(Patrick, Zukerberg et al. 1999). In any case, the outsized impact that defects in the molecular 
motors have on the health of the nervous system clearly demonstrates that the complex 































































































































































































































I.2. Localized Protein Synthesis in Neurons 
 From our examination of the protein machinery comprising the intracellular transport 
system, it should be apparent that much of cellular behavior and function can be explained in 
terms of what proteins a cell contains and where they are. The latter factor—that is, protein 
localization—is substantially determined through the very means of intracellular transport, but 
this is not the only process involved. In fact, recent discoveries have illustrated that, rather than 
being synthesized and then trafficked long distances from their point of origin, some proteins are 
made precisely where they are needed; their localization is thus defined from the beginning of 
their existence. This special mode of localized protein synthesis adds considerable opportunities 
for fine-tuned spatiotemporal control within cellular systems, and it is continually being 
recognized in new contexts and applications. 
 
a. Post-transcriptional regulation and RNA granules 
In his famous “Central Dogma of Molecular Biology,” Francis Crick formulated that the 
flow of genetic information within cells culminates in protein synthesis (Crick 1958), and it was 
soon after shown that this involves, first, the transcription of DNA to mRNA and, then, the 
translation of mRNA by ribosomes to make protein (Brenner, Jacob et al. 1961). At the same 
time, groundbreaking studies on bacterial “operons” demonstrated that induction or repression of 
gene expression occurred at the level of transcription, through different factors that modify the 
rate of mRNA synthesis (Jacob and Monod 1961). For almost two decades after these initial 
discoveries, the conventional understanding dictated that the mRNA intermediate, being short-
lived, did not really afford itself as a target for regulatory control (Darnell Jr 1979). Rather, it 
was expected that the mRNA transcript, once it was fully processed and exported into the 
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cytoplasm, would be translated to synthesize the corresponding protein more or less 
immediately. This limited view of genetic regulatory opportunities began to broaden with the 
realization that mRNAs can have widely differing half-lives, with some persisting for many 
hours, and that such variability in transcript stability can be attributed to differences in how the 
mRNAs are handled after transcription (Lubimova, Chernovskaja et al. 1975, Harpold, Wilson et 
al. 1981). Furthermore, it was observed that accumulation of mRNA and increased protein 
synthesis can occur well out of proportion to any changes in the transcription rate, highlighting 
the genuine importance of post-transcriptional and translational control mechanisms for 
regulating gene expression (Chen and Osborne 1970, Guyette, Matusik et al. 1979). 
Since this shift in understanding, several molecular determinants of cytoplasmic mRNA 
regulation have been identified: miRNAs (Lee, Feinbaum et al. 1993) and the RNA-induced 
silencing complex (Hammond, Bernstein et al. 2000); the exon junction complex, which 
mediates nonsense-mediated mRNA decay (Peltz, Brown et al. 1993); and a multitude of 
sequence-specific RNA-binding proteins (Crawford and Richter 1987). The existence of 
endogenous pathways for mRNA silencing was, of course, an experimental boon, exploited in 
the form of gene expression knockdown via RNAi (Fire, Xu et al. 1998). While not having quite 
the same experimental impact, though, the ongoing characterization of the diverse RBP 
repertoire has, arguably, been the more revolutionary development in recent RNA biology. By 
nucleating RNA-protein complexes called RNPs, we now understand that RBPs form crucial 
regulatory hubs that enable cellular oversight for virtually every aspect of mRNA function, from 
initial processing to translation and degradation (Visa, Alzhanova-Ericsson et al. 1996, Dreyfuss, 
Kim et al. 2002). Notably, many RBPs appear to bind cohorts of functionally related mRNAs, 
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suggesting that the cell might coordinately control the expression of associated genes by 
packaging their transcripts together into the same RNP (Keene and Tenenbaum 2002). 
Within the cytoplasm, RNPs often aggregate into large granules visible by light 
microscopy (Wilsch-Brauninger, Schwarz et al. 1997, Wilhelm, Mansfield et al. 2000), and 
several different types of these granules have been distinguished based on their composition and 
presumed function. The three varieties seen in non-germ cells—and, therefore, most relevant to 
our concerns—are stress granules, processing bodies, and transport particles. Stress granules and 
processing bodies appear to participate in mRNA storage and destruction, respectively (Nover, 
Scharf et al. 1989, Sheth and Parker 2003); transcripts accumulate in these structures particularly 
when global protein synthesis is shut down due to different forms of cellular stress (Kedersha, 
Stoecklin et al. 2005). Whereas stress granules are mainly aggregates of stalled translation 
preinitiation complexes (Kedersha, Chen et al. 2002), processing bodies contain exonucleases, 
decapping enzymes, and RISC components (Bashkirov, Scherthan et al. 1997, Ingelfinger, 
Arndt-Jovin et al. 2002, Sen and Blau 2005), accounting for their distinctively degradative 
function. Transport particles are bundles of mRNA complexed with specific RBPs that associate 
with the intracellular transport machinery and mediate transcript localization into subcellular 
compartments, especially within neurons (Knowles, Sabry et al. 1996). One characteristic that all 
these kinds of granules have in common is that their constituent mRNAs are translationally 
repressed (Richter and Smith 1984), although, in most cases, they seem to be in dynamic 
equilibrium with actively translated mRNAs in polyribosomes (Kedersha, Gupta et al. 1999, 
Barbee, Estes et al. 2006). With regard to transport particles specifically, the inhibition of mRNA 
translation during translocation to the intended subcellular compartment enables the cell to 
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accomplish spatially restricted expression of some proteins (Chartrand, Meng et al. 2002), a 
phenomenon to which we must now turn our attention. 
 
b. Translational capacity of dendrites and axons 
The first examples of asymmetric mRNA localization to be observed and linked to 
functional consequences were in cells preparing to undergo polarized divisions into non-identical 
daughter cells, such as in budding yeast (Long, Singer et al. 1997), Xenopus oocytes (Melton 
1987), or the syncytial blastoderm of early Drosophila embryos (Hafen, Kuroiwa et al. 1984). 
However, extending the logic of localized gene expression to neurons—highly polarized but 
non-dividing cells—had to overcome the received wisdom that translational capacity is restricted 
to the soma (Peters, Palay et al. 1976). This limitation was at least theoretically lifted through the 
detection of protein synthesis machinery in the form of polyribosomes at synaptic contacts under 
dendritic spines (Steward and Levy 1982). Selective transport of mRNA into dendrites would be 
demonstrated soon after (Davis, Banker et al. 1987), no doubt abetted by the contemporaneous 
advances in elucidating post-transcriptional regulation. With mRNA and polyribosomes proven 
to be in dendrites, it was relatively straightforward to establish that even isolated dendrites, 
sheared off of cell bodies, could produce their own protein (Torre and Steward 1992). 
What was true for dendrites, though, was not necessarily so for axons, and the idea of 
intra-axonal protein synthesis would prove to be much more controversial for quite some time. 
From the earliest cytologic studies of neurons, it was evident that mature vertebrate axons, unlike 
cell bodies or dendrites, are largely devoid of Nissl substance (Schaffer 1893), which later 
ultrastructural investigations would show to represent ribosomes (Palay and Palade 1955). 
Similarly, electron micrographs of axons themselves very rarely displayed ribosomes beyond the 
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initial segment (Palay, Sotelo et al. 1968). It was noted that axons from younger organisms, 
especially those gestating or newborn, tend to contain more ribosomes than are seen in adults, 
but this fact does not seem to have been thought of as much more than a curiosity (Zelena 1972). 
Axonal protein synthesis was thus ruled out, considering that the widespread interpretation of the 
data was that axons lacked the molecular machinery for it. Meanwhile, the existence of 
anterograde axoplasmic flow moving organelles and cytoskeletal elements into the axon was 
already well-established (Weiss and Hiscoe 1948), even if its molecular basis remained 
thoroughly unknown. This lent credibility to the supposition of an exclusively somatic origin for 
all the components of the axon, which seemed to many the only viable explanation. Throughout 
the mid-twentieth century, there was sporadic but significant opposition to this apparent 
consensus. In a remarkable series of articles during the 1960s, Edward Koenig showed that, after 
irreversible inhibition, acetylcholinesterase regenerates in axons through a process of local 
synthesis (Koenig and Koelle 1960, Koenig 1965a), and he vigorously defended the existence of 
axonal mRNA (Koenig 1965b, Koenig 1967a, Koenig 1967b). A few investigations followed on 
protein synthesis in synaptosomes, which represent isolated synaptic terminals, but these 
ultimately did little to alter the status quo (Austin and Morgan 1967, Autilio, Appel et al. 1968). 
In the decade after the uncovering of dendritic protein synthesis, refinements in neuronal 
cell culture techniques and the availability of new methods for detecting RNA and protein 
encouraged the reexamination of translational activity in axons, especially during development. 
Beginning with Gary Bassell’s demonstration that axonal growth cones in culture contain 
polyribosomes as well as a specifically localized mRNA, encoding β-actin (Bassell, Zhang et al. 
1998), it was soon realized that a number of cytoskeletal and other proteins are locally produced 
within axons. Puzzlingly at the time, the portion of such proteins as actin or tubulin that was seen 
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to be locally produced was less than 1% of the amount synthesized in the soma and then 
transported into axons; moreover, even when axonal protein synthesis was blocked with 
pharmacologic inhibitors, axons continued to elongate (Eng, Lund et al. 1999). The first proof 
that this small pool of axonally synthesized protein has unique functional significance only came 
later, when it was shown that local translation is part of a number of developmental processes 
stimulated by extrinsic cues: axon repulsion after growth past intermediate targets (Brittis, Lu et 
al. 2002); growth cone collapse or attraction in response to guidance cues (Wu, Hengst et al. 
2005, Leung, van Horck et al. 2006); and axon outgrowth stimulated by neurotrophic factors, but 
not basal elongation (Hengst, Deglincerti et al. 2009). In essence, then, intra-axonal protein 
synthesis appears to be indispensable only for local responsiveness to sensed stimuli, but not for 
carrying out constitutive “housekeeping” functions that are not stimulus-induced. 
 
c. Axonal transcriptomics: injury, degeneration, and regrowth 
In the course of investigating the different functions of axonal protein synthesis, a critical 
resource has emerged in the form of localized mRNA libraries, or transcriptomes. While some of 
these transcriptomes have limited themselves to defining the typical axonal mRNA composition 
of a particular type of neuron (Minis, Dahary et al. 2014), others have taken a more comparative 
approach, such as paralleling results from embryonic and adult axons to determine which 
transcripts change the most based on the developmental stage of the organism (Gumy, Yeo et al. 
2011). In terms of what can be generalized about the axonal transcriptome, from these studies it 
is apparent that transcripts involved in mitochondrial function, cytoskeletal regulation, 
intracellular transport, and protein synthesis—including mRNAs for ribosomal subunits—tend to 
be the most highly enriched in axons. Another important take-away from this basic profiling of 
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axonal mRNA is that the vast majority of transcripts detectable in the axon are not found in the 
axon’s growth cone (Zivraj, Tung et al. 2010), indicating that distinct mechanisms exist for 
mRNA localization to the axon or selectively to the growth cone. 
Among the most intriguing transcriptomes generated have been those which took the 
stimulus dependence of local translation into account and assayed, for example, how the 
axonally localized mRNA repertoire responds to axonal injury (Willis, van Niekerk et al. 2007, 
Taylor, Berchtold et al. 2009) or the presence of a toxic stressor (Baleriola, Walker et al. 2014). 
These libraries are extremely useful in highlighting for further study potential translation-
dependent pathways in the axon’s response to various insults and challenges. A few major 
players in such pathways have already been identified. After axonal injury, locally produced 
importin β1 (Hanz, Perlson et al. 2003), vimentin (Perlson, Hanz et al. 2005), RanBP1 (Yudin, 
Hanz et al. 2008), and STAT3 (Ben-Yaakov, Dagan et al. 2012) assemble a retrogradely 
transported signal that informs the cell body about the lesion, while intra-axonal synthesis of β-
actin, neurofilaments, and other factors facilitate regrowth (Zheng, Kelly et al. 2001, Donnelly, 
Willis et al. 2011). Recently, it was also shown that axons exposed to neurotoxic oligomers of 
amyloid-β respond by recruiting mRNA for the transcription factor ATF4, which is then 
synthesized in axons and retrogradely transported to induce changes in gene expression at the 
nucleus (Baleriola, Walker et al. 2014). From what we have learned through transcriptome 
profiling and previous characterization of locally produced proteins, there seem to be two 
overarching roles for axonal protein synthesis that have strong evidentiary support: first, the cell 
body-independent control of morphologic and physiologic changes within axons, and, second, 
the propagation of axon-to-soma signals concerning the dynamic state of the neuronal periphery. 
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I.3. Support Signals and Stressors of the Neuronal Environment 
 Neuronal physiology does not depend merely on the intrinsic pathways of wholly 
autonomous cells, whether these are directed from the soma or locally organized. Instead, as we 
have seen, albeit obliquely, extrinsic signals play a major role in informing the cell about its 
surroundings and instructing it to adapt to changing conditions. Neurons react to many factors in 
their environment, including small-molecule neurotransmitters, neuropeptides, growth signals, 
hormones, matrix material, and even dysfunctional proteins that accumulate there. Reviewing all 
these substances in detail is not our present concern, but two types—neurotrophins and 
amyloids—merit special consideration given their relevance to the development and 
degeneration of the nervous system. 
 
a. Neurotrophins, their receptors, and signaling endosomes 
Neurotrophins are a family of structurally related, secreted proteins that support the 
survival of vertebrate neurons (Leibrock, Lottspeich et al. 1989), comprising four known 
members: nerve growth factor, the founder and prototype of the family (Cohen and Levi-
Montalcini 1956); brain-derived neurotrophic factor (Barde, Edgar et al. 1982); NT-3 (Hohn, 
Leibrock et al. 1990, Maisonpierre, Belluscio et al. 1990); NT-4/5 (Berkemeier, Winslow et al. 
1991, Hallböök, Ibáñez et al. 1991); and two homologues only found in fish, NT-6 (Gotz, Koster 
et al. 1994) and NT-7 (Nilsson, Fainzilber et al. 1998). During development, NTs secreted by 
target cells help to direct growing axons of specific neuron types towards them (Gundersen and 
Barrett 1979, Phillips, Hains et al. 1990), a phenomenon known as their “tropic” effect. As their 
name suggests, NTs also have a distinct “trophic”—or, more accurately, pro-survival—effect, 
and certain kinds of neurons, especially during development, cannot survive in their absence 
26 
 
(Levi-Montalcini and Angeletti 1963). Embryonic DRG neurons, for example, go through a 
requisite period of dependence upon NGF, during which time experimentally induced 
autoimmunization of the organism to NGF will result in near-total destruction of these sensory 
ganglia (Johnson, Gorin et al. 1980). It is commonly understood that this NT dependence is a 
developmental mechanism to select for neurons whose axons have made the most optimal 
connections in their intended target field. Assuming a limiting supply of NTs, such neurons will 
outcompete and thus survive, while those with less suitable connections undergo apoptosis 
(Heumann, Korsching et al. 1984, Harper and Davies 1990). This idea is called the “neurotrophic 
hypothesis,” and it has become the most useful model for understanding NTs’ physiologic role in 
vivo. 
Cellular responsiveness to NTs is mediated by two kinds of surface receptors, p75
NTR
 and 
Trk receptors, with distinct binding characteristics and downstream effectors [FIGURE 1-B] 
(Sutter, Riopelle et al. 1979, Meakin and Shooter 1991). p75
NTR
 belongs to the tumor necrosis 
factor receptor superfamily (Banner, D'Arcy et al. 1993) and was first identified as a low-affinity 
receptor for NGF (Johnson, Lanahan et al. 1986), although later research would demonstrate that 
it also binds other NTs with similar affinity (Rodriguez-Tebar, Dechant et al. 1990). The Trk 
proteins, meanwhile, are higher-affinity receptors with different NT specificities: TrkA binds 
NGF and NT-3 (Cordon-Cardo, Tapley et al. 1991, Klein, Jing et al. 1991); TrkB is activated by 
BDNF, NT-3, and NT-4/5 (Soppet, Escandon et al. 1991, Squinto, Stitt et al. 1991, Klein, 
Lamballe et al. 1992); and TrkC is only known to bind NT-3 (Lamballe, Klein et al. 1991). The 
primary means of NT survival signaling from binding at the plasma membrane is through these 
Trk receptors (Glass, Nye et al. 1991, Kaplan, Hempstead et al. 1991), which function by 
dimerizing in the presence of ligand to activate their kinase activity (Jing, Tapley et al. 1992). In 
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addition to this homodimerization, there is also evidence that p75
NTR
 can interact with TrkA to 
potentiate its activation, particularly in response to low concentrations of NGF (Hempstead, 
Martin-Zanca et al. 1991, Verdi, Birren et al. 1994). However, on its own, p75
NTR
 has actually 
been implicated in initiating mainly pro-apoptotic, rather than pro-survival, signaling 
(Rabizadeh, Oh et al. 1993, Frade, Rodriguez-Tebar et al. 1996). 
There has long been evidence that NTs, upon binding at axon terminals, can be 
internalized by the cell and undergo retrograde axonal transport (Hendry, Stockel et al. 1974, 
Bernd and Greene 1984). It even appears that some of the effects of NTs, such as in regulating 
new transcription, might be directly mediated by their translocation to the nucleus (Johnson, 
Andres et al. 1978, Riccio, Pierchala et al. 1997), providing a biological justification for this 
long-range transport. Inquiries into this process culminated in the finding that NTs are subject to 
Trk-receptor mediated endocytosis and packed into small organelles, dubbed “signaling 
endosomes,” that are retrogradely transported (Grimes, Zhou et al. 1996). Since this discovery, it 
has generally been assumed that signaling endosomes are integrally involved in the neurotrophic 
response, although other studies have delineated signaling endosome-independent consequences 
of Trk receptor activation, including calcium signaling and local protein kinase cascades 
(Tinhofer, Maly et al. 1996, Markus, Zhong et al. 2002). In fact, contrary to the “signaling 
endosome hypothesis,” several groups have found that NTs’ support of survival does not require 
Trk receptor internalization or retrograde trafficking of signaling endosomes (Zhang, Moheban et 
al. 2000, MacInnis and Campenot 2002). 
Clearly, much about Trk receptor signaling, both in the presence and absence of bound 
ligand, remains imperfectly understood, and so different hypothetical frameworks continue to be 
fashioned. Recently, new studies have claimed that TrkA and TrkC, but not TrkB, function at 
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least in part as “dependence receptors,” meaning that, far from being inert when in their NT-
unbound state, these receptors constitutively induce pro-apoptotic death pathways which only 
cease when they bind ligand (Tauszig-Delamasure, Yu et al. 2007, Nikoletopoulou, Lickert et al. 
2010). Combined with another recent report strongly attributing the effects of NGF deprivation 
to the activation of a pro-apoptotic signaling pathway rather than the loss of retrogradely 
transported survival signals (Mok, Lund et al. 2009), this emerging evidence suggests that much 
of what we think we know about neurotrophic signaling might warrant reexamination. 
 
b. Paradigms of neurodegeneration: neurotrophin deprivation and amyloid toxicity 
Post-developmentally, NTs and their receptors continue to be expressed and play vital 
roles in the maintenance of the nervous system, regulating neurite morphology (Diamond, 
Holmes et al. 1992), synaptic plasticity (Kang and Schuman 1995), and neuronal responses to 
injury (Merlio, Ernfors et al. 1993). Given its enduring importance to neuronal function and 
adaptability, NT signaling has repeatedly been investigated as a potential cause or even 
therapeutic avenue in neurodegenerative diseases. In glaucoma, strong evidence exists that 
ocular hypertension causes NT deprivation and Trk receptor dysregulation, which lead, in turn, 
to the death of retinal ganglion cells (Rudzinski, Wong et al. 2004, Dekeyster, Geeraerts et al. 
2015). Downregulation of NTs and Trk receptors has also been seen to correlate with the 
progression of AD, especially in brain regions and cell types that tend to be the most severely 
affected, although these do not appear to be early or precipitating factors (Phillips, Hains et al. 
1991, Salehi, Verhaagen et al. 1996, Ginsberg, Che et al. 2006).  
Indeed, identifying the chief pathogenetic event in AD has proven extremely 
controversial, with most investigators dividing between two camps that each advocate a single 
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pathological protein as key—the microtubule-associated protein tau or amyloid-β (Jack Jr and 
Holtzman 2013). One advantage of studying Aβ is that well-established methods exist to survey 
its neurotoxic effects in vitro (Yankner, Duffy et al. 1990), although this is, admittedly, artificial 
and may have little bearing on resolving the dispute as to what actually happens in AD patients. 
Little is known about the transition of Aβ from its physiologic role in modulating synaptic 
plasticity (Kamenetz, Tomita et al. 2003, Puzzo, Privitera et al. 2008, Puzzo, Privitera et al. 
2011) towards pathology, but the details of its production have been fleshed out extensively. Aβ 
is formed by proteolytic cleavage of a transmembrane glycoprotein, amyloid precursor protein 
(Kang, Lemaire et al. 1987), at two distinct sites, catalyzed by the beta-secretase BACE1 and a 
gamma-secretase complex [FIGURE 1-C] (Vassar, Bennett et al. 1999, Li, Lai et al. 2000). The 
release of the soluble Aβ fragment occurs normally in healthy individuals (Shoji, Golde et al. 
1992), but one of the striking characteristics of AD is that extracellular Aβ aggregates into 
insoluble fibrils and then large neuritic plaques (Masters, Simms et al. 1985). Research has 
found, however, that the most potent toxic species of Aβ is not in fibrils or plaques but rather in 
diffusible oligomers (Lambert, Barlow et al. 1998). 
Interestingly, as alluded to before, Aβ oligomers have recently been shown to stimulate 
local protein synthesis, which helps to mediate their toxicity (Baleriola, Walker et al. 2014), and 
NTs’ effects on synaptic plasticity in the adult brain also appear to require the local production of 
protein (Kang and Schuman 1996). These results suggest that the use of localized protein 
synthesis in facilitating neuronal responses to extracellular stimuli might be a mechanism that is 
























































































































































































































































































































































































I.4. Outline of Thesis 
 Thus far, we have reviewed three biological operations, all germane to the functioning of 
neurons, that might nevertheless seem to be largely unrelated. It is true, for instance, that NT 
signaling endosomes undergo active transport by molecular motors and that environmental cues 
can trigger the local production of certain proteins, but, as things stand, these facts do not clearly 
inform each other. However, these three operations could be fitted into a theoretical physiologic 
pathway, proceeding neatly in reverse relative to how they were introduced: viz. extracellular 
stimuli and changing environmental conditions near axons may induce local protein synthesis as 
a mechanism to fine-tune axonal transport for meeting new demands. What follows in this thesis 
is a demonstration that this proposed pathway belongs not merely to the realm of speculation but 
is, in fact, substantiated by new evidence as actually taking place in mammalian neurons. 
 In Chapter II, the materials and experimental procedures used in the described studies are 
detailed. Chapter III establishes that mRNAs associated with dynein-based transport are recruited 
to axons and undergo regulation, at the level of localization as well as translation, in response to 
different conditions of NT signaling. The surprisingly complex post-transcriptional regulation of 
axonally localized mRNA for the cofactor Lis1 is given special consideration. Chapter IV shows 
that NT-related changes in axoplasmic transport are mediated by localized protein synthesis, 
with locally produced Lis1 and p150
Glued
 being important regulators of retrograde transport. 
Preliminary evidence for transport regulation via axonal protein synthesis in the context of pre-
neurodegenerative stress is provided in Chapter V. Lastly, in Chapter VI, the present findings are 
situated in terms of the literature, and their implications for future research are explored. Overall, 
this thesis aims to broaden our conception of regulatory opportunities in polarized cells, with its 
presentation of a novel mechanism for regulating intracellular transport as a revealing exemplar. 
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CHAPTER II. MATERIALS AND METHODS 
 
II.1. Animal Use 
a. Rat ordering and husbandry 
 Timed-pregnant Sprague-Dawley rats (Rattus norvegicus) were obtained from Charles 
River Laboratories (Wilmington, MA) and housed in a high-level barrier facility at the Columbia 
University Institute of Comparative Medicine. All rodent procedures were approved by the 
Columbia University Institutional Animal Care and Use Committee. 
 
b. Euthanasia 
 Consistent with recommendations from the Panel on Euthanasia of the American 
Veterinary Medical Association, rats were euthanized by gas displacement with 10% min
-1
 CO2 













II.2. Cell Culture Techniques 
a. Microfluidic devices 
 Tripartite microfluidic devices with two sets of 200 µm-long microgroove barriers were 
produced according to published protocols [FIGURE 2-A] (Park, Vahidi et al. 2006, Desai, 
Freeman et al. 2009). In summary, microfluidic chambers were produced using polyurethane 
plastic replica molds made from silicon masters. PDMS elastomer base was combined with 
curing agent (Ellsworth, Germantown, WI) in a 9:1 ratio and mixed thoroughly for 5-10 min. 
The PDMS mixture was then poured onto the plastic mold, and the mold was placed in a vacuum 
desiccator for approximately 30 min to remove trapped bubbles from the PDMS. Afterward, the 
mold was put in a leveled oven so that the PDMS could cure for at least 4 h at 65°C. Using a 
razor blade, the cured PDMS was removed from the mold and cut into the individual chamber 
devices. For each device, a 6.0 mm biopsy punch (VWR, Radnor, PA) was used to punch out the 
six reservoirs. Debris was cleaned from the surface of the chambers using vinyl cleanroom tape 
(VWR), and the devices were sterilized by brief immersion in 70% EtOH. Lastly, the devices 
were dried for at least 1 h in a laminar flow hood before application. 
 
b. Culture material preparation 
 Nunc cell-culture treated 6-well plates or, in the case of live-imaging experiments, glass 
bottom dishes (MatTek, Ashland, MA) were utilized for cell culture. 25 mm circular cover 
glasses (Carolina Biologicals, Burlington, NC)—which, for DRG culture only, were immersed 
overnight in nitric acid and then rinsed with water until neutralized—were placed in each well of 
a 6-well plate. Cover glasses or glass bottom dishes were coated with 100 µg ml
-1
 PDL (Sigma-
Aldrich, St. Louis, MO) for hippocampal culture or PLL (Trevigen, Gaithersburg, MD) for DRG 
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culture; incubation with PDL or PLL was performed for 1 h, after which the coated surface was 
washed three times with sterile water and then dried. 
 
c. Beginning dissection 
After euthanasia, the pregnant dam’s uterus was dissected out and placed in a sterile dish. 
Embryos were removed from the uterus within a positive pressure hood for further dissection. 
 
d. DRG neuron culture 
 Primary DRG neurons were harvested from E15 rat embryos. DRGs were removed from 
the embryos and placed in a dish containing Leibovitz’s L-15 medium. The collected DRGs were 
put in a 15 ml conical centrifuge tube with TrypLE Express and incubated for 20 min in a water 
bath at 37°C. Trypsinized DRGs were then centrifuged for 5 min at 1000 rpm in 4°C. Afterward, 
the TrypLE solution was carefully removed from the pelleted tissue, which was resuspended in 
DRG medium (Neurobasal, 1x B27, 2 mM glutamate, 20 µM 5-FdU, 50 ng ml
-1
 NGF) and 
dissociated by ten passes through a 1 ml pipette followed by ten more passes through a 100 µl 
pipette (VWR). Subsequently, approximately 60,000 cells were seeded per chamber. 
 
e. Hippocampal neuron culture 
 After applying the microfluidic chambers, the cover glasses or glass bottom dishes for 
hippocampal cultures were coated with 2 μg ml
-1
 laminin (Trevigen, Gaithersburg, MD). 
Primary hippocampal neurons were prepared from E18 rat embryos based on a well-
established protocol (Banker and Goslin 1998). The embryos’ brains were dissected out and 
placed in a dish containing HBSS. Once all of the hippocampi were isolated, they were put 
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together in a 15 ml conical centrifuge tube with TrypLE Express and incubated for 20 min in a 
water bath at 37°C. Trypsinized hippocampi were then centrifuged for 5 min at 1000 rpm in 4°C. 
Afterward, the TrypLE solution was carefully removed from the pelleted tissue, which was 
resuspended in hippocampal plating medium (Neurobasal, 10% FBS, 100 mM glutamine) and 
dissociated by ten passes through a regular glass Pasteur pipette followed by ten more passes 
through a flame-polished pipette. Cell density in the resulting suspension was measured with a 
hemacytometer and adjusted, with 60,000 cells ultimately being seeded per chamber. On DIV 1, 
the medium was changed to a serum-free growth medium (Neurobasal, 1x B27, 100 mM 












FIGURE 2-A: Schematic representation of a microfluidic chamber used to isolated axons. 
Embryonic DRG or hippocampal neurons (red) were seeded in the cell body compartment 
(green), and their axons extended through two microgroove barriers (blue) into the axonal 
compartments (orange). All axon-specific treatments were applied to both axonal 






II.3. Experimental Interventions 
a. RNA interference with siRNAs 
 Axon-specific silencing of Pafah1b1 and Dctn1 mRNAs was achieved by transfecting 
siRNAs into axons, concomitant with a medium exchange, using NeuroPORTER (Genlantis, San 
Diego, CA) as the transfection reagent. In brief, a mixture of 100 nM siRNA and 10% 
NeuroPORTER in serum- and antibiotic-free medium was added to axonal compartments. For 
hippocampal neurons only, 2 h after transfection the axonal medium was supplemented with an 
equal volume of Neurobasal containing 2x B27 and 100 nM glutamine; thus, in hippocampal 
neuron experiments, the final siRNA concentration was 50 nM. The following siRNAs were 
used to target rat Pafah1b1 (NM_031763.3) and Dctn1 (NM_024130.1):  
Pafah1b1 siRNA.1- 5′CCUUUGACCACAGUGGCAAACUCUU3′ 
Pafah1b1 siRNA.2- 5′GGAUUUCCAUAAGACGGCACCCUAU3′; 
Dctn1 siRNA.1- 5′GAGCGCUCCUUAGAUUUCCUCAUCG3′  
Dctn1 siRNA.2- 5′GACAUCCGUCAGUUCUGCAAGAAGA3′. 
Stealth RNAi siRNA Negative Control Med GC Duplex #3 was used as a negative control.   
 
b. LNA transfection 
Custom-made LNAs, designed to have fewer than five unmodified bases in a row so as to 
prevent RNase H recruitment and activation (Kurreck, Wyszko et al. 2002), were ordered from 
Exiqon (Woburn, MA) with HPLC purification. By a similar procedure to that described above 
for transfection of DRG axons with siRNA, 100 nM LNAs were transfected into the cell body 
compartment using NeuroPORTER. One LNA (5’-A+TTTA+CAGTA+TACAA+TT-3’) 
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targeted the CUGU-motif APC binding site (bases 1905-1921) of rat Pafah1b1 mRNA, while a 
control LNA (5’-CA+TGAA+TACTT+TGT-3’) was made to target an unrelated, upstream 
sequence (bases 1878-1891) [FIGURE 2-B]. +A/+C/+G/+T signify modified LNA bases. 
 
c. Pharmacological inhibitors 
 When specified, the following inhibitor compounds were applied specifically to axons in 
microfluidic cultures: protein synthesis inhibitors anisomycin (1 µM, Sigma-Aldrich) or emetine 
(2 µM, EMD Millipore, Billerica, MA); mTOR inhibitor rapamycin (10 nM); MLK inhibitor 
CEP-1347 (0.5 µM); p38 MAPK inhibitor SB239063 (1 µM); GSK3 inhibitors LiCl (15 mM) 
or SB216763 (10 µM, Sigma-Aldrich); or the dynamin inhibitor dynasore (80 µM, Sigma-
Aldrich). 
 
d. Nerve growth factor and amyloid-β 
 2.5S NGF (Harlan, Indianapolis, IN) was dissolved in buffer consisting of 0.1 M sodium 
acetate and 0.5 M sodium chloride at pH 5.0, aliquoted, and stored at -80°C until use. 
Soluble oligomeric Aβ was prepared according to an established protocol (Stine, 
Dahlgren et al. 2003). Synthetic Aβ1-42 peptides (purchased from Dr. David Teplow, UCLA) 
were dissolved in hexafluoroisopropanol to a concentration of 1 mM, aliquoted, and dried. The 
peptides were resuspended to 1 mM in DMSO through bath sonication for 10 min and stored at   
-20°C. For oligomer formation, the peptides were diluted to 100 μM in PBS, incubated overnight 




e. In vivo retrograde tracing experiments 
 Stereotaxic injections were performed according to established procedures 
(Sotthibundhu, Sykes et al. 2008) with minor modifications (Jean, Ribe et al. 2013). 9-12 month-
old C57Bl/6J mice (Jackson Laboratory, Bar Harbor, ME) were anesthetized with ketamine (95 
mg kg
-1
) and xylazine (7 mg kg
-1
), and then placed in a stereotaxic frame (Stoelting, Wood Dale, 
IL). Stereotaxic injections were conducted using convection-enhanced delivery at a rate of 0.5 μl 
min
-1
 using the Quintessential Stereotaxic Injector (Stoelting). Mice were injected with 4 μl 
DMSO into the left dentate gyrus and 4 μl oligomeric Aβ1-42 (100 μM in PBS) into the right 
dentate gyrus [FIGURE 2-C]. Based on the observed spread of Aβ1-42, the estimated final Aβ1-42 
concentration was ∼30 nM in the dentate gyrus. A 2% suspension of the retrograde label 
FluoroGold (Fluorochrome, LLC, Denver, CO) was co-injected in all cases. Animals were 
sacrificed 2, 4, or 7 days post injection by anesthesia with ketamine and xylazine followed by 
transcardial perfusion with 4% PFA in PBS. Brains were post-fixed in 4% PFA for 24 hr at 4°C, 
followed by 30% sucrose infiltration, embedded in Tissue-Tek O.C.T Compound (Sakura 
Finetek, Torrance, CA), and cryostatically sectioned at 20 μm thickness. Finally, sections of the 
basal forebrain, which includes populations of neurons that project axons to the dentate gyrus 
(Amaral and Kurz 1985, Leranth and Frotscher 1989), were imaged for FluoroGold labeling. 
 
Figure E
FIGURE 2-B: Partial sequence of the 3’UTR of rat Pafah1b1 starting at the stop codon (*). 
The binding regions of the CUGU and control LNA oligomers are indicated in green and 





























































































































































































































































































II.4. Immunocytochemistry and Functional Imaging 
a. Microscope set-up and image acquisition 
 Neurons were imaged using a Plan-Apochromat 63x/1.40 oil objective on an Axio-
Observer.Z1 motorized inverted microscope equipped with an AxioCam MRm Rev. 3 camera 
(Zeiss, Thornwood, NY). This microscope’s filter set allows three-channel detection of 
fluorophores from the DAPI (Em = 461 nm), eGFP (Em = 509 nm), and Texas Red (Em = 615 
nm) families. During live-cell imaging, a heat-controlled microscope chamber incubator together 
with a temperature-, CO2-, and, humidity-controlled stage incubator allowed samples to be kept 
at 37°C and 5.0% CO2, while a Definite Focus module (Zeiss) prevented Z-drift during the 
relatively long-term observation. 
Exposure settings for image acquisition of stained axons were determined automatically 
using AxioVision 4.8 acquisition software (Zeiss) on a random axonal field of a control sample, 
to ensure that pixel intensities were within the linear range and avoid pixel saturation. These 
settings were then maintained for all samples in any given experiment. Images were focused 
based on the counterstain so that acquisition would be blind to the staining of interest. For fixed 
samples, images were acquired in Z-stacks of three slices in five random fields per cover glass; 
Z-slices of axonal fields were 0.1 μm apart, whereas those in somatic fields were 1 μm apart. 
 
b. Fixation and blocking 
 Neurons were fixed with 4% PFA/4% sucrose in PBS for 20 min at room temperature. 
Afterward, cover glasses were washed three times in PBS, then blocked and permeabilized for 




c. Quantitative immunofluorescence 
After fixation and blocking, neurons were incubated with primary antibodies against two 
or more of the following targets: β-III tubulin (Abcam, ab7751; 1:500), 4E-BP1, phospho-4E-
BP1, S6, phospho-S6 (Cell Signaling Technology, 1:1,000), Lis1 (Sigma-Aldrich, SAB3500302, 
1:400), or p150
Glued
 (Abcam, ab11806, 1:500). Then, cover glasses were washed three times with 
TBS and incubated with fluorophore-conjugated Alexa secondary antibodies (1:2,000) for 1 h at 
room temperature, washed three more times with TBS, and mounted with ProLong Gold antifade 
reagent. Staining for β-III tubulin was used to generate a mask within which the pixel intensity of 
the immunofluorescence signal for the protein of interest was quantified. For each image, 
background pixel intensity was calculated outside the axonal mask and subtracted from the 
signal for the protein of interest. 
 
d. Live-cell imaging of axonal cargoes 
To assess generic axonal trafficking, 50 nM LysoTracker Green DND-26 was added to 
axons during an axonal medium exchange 15 min prior to the start of imaging. For examining 
transport specifically of NGF-containing endosomes, quantum dot-conjugated NGF was 
prepared by mixing mouse NGF 2.5S-Biotin (Alomone Labs, Jerusalem) and Qdot 585 
Streptavidin Conjugate in a 1:1.2 molar ratio and incubating them together at 4°C with 
continuous inversion for 24 h. The next day, QD-NGF was diluted to 100 ng ml
-1
 and added to 
axons with a medium change 15 min before imaging. During imaging, neurons were kept in a 
CO2- and humidity-controlled incubation chamber maintained at 37°C. Images were acquired 
every 13 s over a total 4-minute time period, with 3 fields of axons imaged per replicate. 
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For motility analysis, LysoTracker-positive particles were scored only if they were ≥1 μm 
in diameter, whereas QD-NGF particles were included only if they were ≤0.5 μm in diameter. 
Particles were scored as stationary, anterograde, retrograde, or bidirectional according the 
following definitions: stationary if they traveled a distance <1 μm during the observation period; 
anterograde or retrograde if they displaced >3 μm in one direction; and bidirectional if they 
traveled >3 μm in both directions. 
 
e. Cell death and survival assays 
 When complete neutralization of all residual NGF activity in culture was needed, an anti-
NGF antibody (10 µg ml
-1
, ab6198, Abcam) was added with NGF-free medium to both the 
somatic and axonal compartments or to the somatic compartment alone. 
To detect apoptotic cell death, TUNEL was performed on fixed samples using the 
DeadEnd Fluorometric TUNEL System (Promega, Madison, WI), consistent with the 
manufacturer’s instructions but employing modifications for use in microfluidic devices. Cells 
were permeabilized for 1 h with BGT buffer, and then washed three times in PBS. Equilibration 
buffer was added to all compartments for 30 min to pre-equilibrate, after which incubation buffer 
(45 parts equilibration buffer, 5 parts nucleotide mix including fluorescein-12-dUTP, and 1 part 
TdT enzyme) was added only to the somatic compartment. For the TUNEL reaction, samples 
were incubated at 37°C for 1 h, and, to stop the reaction, the microfluidic chambers were 
removed and 2x SSC was added. Finally, cover glasses were washed three more times in PBS, 
dried, and mounted with ProLong Gold antifade reagent with DAPI prior to imaging. 
Meanwhile, survival was analyzed using calcein staining of living cells. Cell bodies were 
incubated with 4.17 μg ml
-1
 calcein AM dye in DMSO for 40-60 min at 37°C. At that point, 
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calcein was quenched with 15 mg ml
-1
 bovine hemoglobin (Sigma-Aldrich), and nuclei were 
labeled with Hoechst stain. Cells were immediately live-imaged inside the microscope 
incubation chamber kept at 37°C and 5% CO2. 
TUNEL-positive nuclei with apoptotic morphology (pyknosis, karyorrhexis) and calcein-





















II.5. Detection of RNA 
a. Fluorescence in situ hybridization 
 Antisense riboprobes were transcribed in vitro from sense oligonucleotides containing a 
T7 promoter site (…GCCCTATAGTGAGTCGTATTAC-3′) at their 3′ end 
using the MEGAshortscript T7 Transcription Kit and digoxigenin-conjugated UTP (Roche, 
Indianapolis, IN), according to the manufacturer’s instructions. In short, the reaction mixture was 
assembled with nucleotides, T7 enzyme, and 200 nM template DNA, gently mixed, and 
incubated at 37°C for at least 2 h. In the last 15 min of the 37°C incubation, TURBO DNase was 
added to degrade the template DNA. After their in vitro transcription, a mix of five non-
overlapping riboprobes with matching GC content was used to detect each mRNA: 
Gfp probe.1-  
5′-GATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAG-3′  
Gfp probe.2-  
5′-GACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTAG-3′  
Gfp probe.3-  
5′-ACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACG-3′  
Gfp probe.4-  
5′-AAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAG-3′  
Gfp probe.5-  
5′-AGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGG-3′;  
 




Pafah1b1 probe.2:  
5'-GGATCTGAGACTAAAAAAAGTGGCAAGCCTGGACCCTTCTTGCTATCTGG-3′  
Pafah1b1 probe.3:  
5'-CTGTTGGTGCCTGACTTGATGGCCTCATTTTGGGGAAAGTGGTTATTAGG-3′  
Pafah1b1 probe.4:  
5′-CTAAGCTGAGAGAAAGTCACTTTATTCTCCCCTCTAATGGGCCATTCACC-3′  
Pafah1b1 probe.5:  
5′-TACTGTTTTCTCTGTCTGCTGTCTAACCCTGTGCCTTGCCTGGGATAAGG-3′;  
 
Dctn1 probe.1:  
5'-TTGGAGATCCTCAAGGCTGAAATTGAAGAGAAAGGCTCTGATGGGGCTGC-3′  
Dctn1 probe.2:  
5'-TCACCAAGGCCATCAAGTACTACCAGCATCTGTACAGCATCCACCTCGCT-3′  
Dctn1 probe.3:  
5'-CAACAGATATTGCTCTTCTTCTGCGAGACCTGGAAACATCCTGCAGTGAC-3′  
Dctn1 probe.4:  
5′-AAGGATGCTGATGAGCGAATCGAGAAAGTTCAGACTCGGCTGGAGGAGAC-3′  
Dctn1 probe.5:  
5′-GGCCAAGGAAGAGCAGCAAGACGACACAGTCTACATGGGCAAAGTGACCT-3′.  
FISH was performed consistent with a published protocol (Femino, Fay et al. 1998), with 
minor modifications. Neurons grown in microfluidic chambers were fixed in 4% PFA/4% 
sucrose in PBS for 20 min at room temperature. Following three washes with PBS, the cells were 
permeabilized with 0.5% Triton X-100 in PBS and washed twice more with PBS. The coverslips 
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were incubated with a total of 100 ng digoxigenin-labeled riboprobes (20 ng each of five distinct 





 salmon sperm DNA) overnight at 37 °C. The coverslips were washed with 
constant agitation at 37 °C, first with 50% formamide in 2x SSC for 30 min followed by 50% 
formamide in 1x SSC for another 30 min. An additional three washes were done at room 
temperature with 1x SSC for 15 min each. The coverslips were washed three times with PBS-T 
for 5  min each, blocked with 3% BSA in PBS-T for 30  min, and incubated with anti-digoxin 
(Sigma-Aldrich, DI-22; 1:500) and anti-β-III tubulin (Abcam, ab41489; 1:1,000) antibodies in 
blocking solution overnight at 4 °C. The coverslips were washed three times with PBS-T and 
incubated with fluorophore-conjugated Alexa secondary antibodies (1:2,000) for 1 h at room 
temperature, washed and mounted with ProLong Gold antifade reagent. 
Staining for β-III tubulin was used to generate a mask within which the pixel intensity of 
the FISH signal was quantified. For each image, background pixel intensity was calculated 
outside the axonal mask and subtracted from the FISH signal. Finally, average fluorescence 
intensity of axonal fields that were incubated with a non-targeting Gfp probe was subtracted from 
the fluorescence intensities resulting from hybridization with Pafah1b1 or Dctn1 riboprobes. 
 
b. RNA purification 
RNA was purified from the axonal compartments of microfluidic chambers using the 
PrepEase RNA Spin kit (Affymetrix, Santa Clara, CA). Axons were lysed with RA1 buffer, and, 
for each condition, lysates from six microfluidic devices were pooled, to which 1% BME was 
added. After vigorous vortexing, lysates were added to filter units (purple), centrifuged at 
11,000x g for 1 min, and equal volume of 70% EtOH was added to the flow-through. Samples 
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were then bound to RNA spin columns (light blue) by centrifugation at 8,000x g for 30 s, and 
eluent was discarded. Membrane desalting buffer was added to the spin column, centrifuged at 
11,000x g for 1 min, and discarded. DNase reaction mixture (1 part rDNase stock solution to 9 
parts DNase reaction buffer) was applied directly to the spin column membrane and incubated at 
room temperature for 15 min. The spin column was subsequently washed three times: first, with 
RA2 buffer, centrifuged at 8,000x g for 30 s; second, with RA3 buffer, centrifuged at 8,000x g 
for 30 s; and lastly, again with RA3 buffer, centrifuged at 11,000x g for 2 min. After air-drying 
the membrane, RNA was eluted by adding 100 μl of RNase-free water directly to the spin 
column and centrifuging at 11,000x g for 1 min. 
A total amount of approximately 2 ng was generally isolated from axonal lysates, which 
was cleaned and concentrated with the RNeasy MinElute Cleanup kit (QIAGEN, Valencia, CA). 
350 μl of RLT buffer was added to the 100 μl sample, followed by 250 μl of pure EtOH, and 
mixed well. Next, the 700 μl of diluted RNA was transferred to a spin column, centrifuged at 
8,000x g for 15 s, and the eluent discarded. The membrane was then washed three times: twice 
with RPE buffer, centrifuged at 8,000x g for 15 s; and then with 80% EtOH, centrifuged at 
8,000x g for 2 min. To dry the membrane, the spin column was centrifuged at full speed without 
its lid for 5 min. Finally, RNA was eluted by adding 10 μl of RNase-free water directly to the 
membrane and centrifuging at full speed for 1 min. 
 
c. Real-time reverse transcription PCR 
Concentrated RNA was reverse-transcribed into cDNA using SuperScript III First-
Strand Synthesis SuperMix. Briefly, axonal RNA, 50 μM oligo(dT)20 primers, annealing buffer, 
and nuclease-free water were combined, incubated in a thermal cycler at 65 °C for 5 min, and 
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then placed on ice for 1 min. Afterward, reaction mix and SuperScript III enzyme mix were 
added, and the reaction was incubated at 50 °C for 50 min before termination at 85 °C for 5 min. 
Real-time RT-PCR was performed using TaqMan Gene Expression master mix with TaqMan 
probe and primer sets for Gapdh (Rn01775763_g1), Pafah1b1 (Rn00443070_m1), and Dctn1 
(Rn00577061_m1) in a StepOnePlus Real-Time PCR instrument. Amplification was 
accomplished using the following conditions: an initial denaturation step at 95°C for 10 min, 
followed by 40 cycles of denaturation at 95°C for 15 s and extension at 60°C for 1 minute. Each 
condition was subjected to three technical replicates per experiment. Relative gene expression 
was quantified by the comparative CT method, and Pafah1b1 and Dctn1 transcript levels were 
















II.6. General Notes 
a. Source of materials 
All reagents or materials were purchased from Thermo Fisher Scientific (Waltham, MA) 
unless otherwise noted. 
 
b. Statistical analyses 
Two means were compared by Mann-Whitney U tests, whereas multiple means were 
compared using Kruskal-Wallis ANOVA with Dunn’s multiple comparison testing. When 
comparing multiple groups in experiments with more than one variable, as was most common, 
two-way ANOVA was performed. 
 
c. Respective contributions 
Joseph M. Villarin performed and analyzed all in vitro experiments, with assistance from 
Ethan P. McCurdy specifically for immunostaining translation markers and scoring some of the 
cell death and survival assays. Dr. Jimena Baleriola from the Hengst laboratory and Dr. Ying 
Jean from the Troy laboratory performed in vivo injection experiments on mice and provided 
unpublished data for analysis by the author, allowing us to report and discuss them here. 
 
d. Publication status 
 The content of Chapters III and IV has been composed into a manuscript, and it is 
planned to be published soon, with a small amount of additional work. Chapter V will likely be 
further developed by Ethan P. McCurdy and others from the Hengst laboratory, thus forming the 
basis for a likely follow-up publication. 
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CHAPTER III. TRANSCRIPTS ENCODING DYNEIN COFACTORS ARE 
LOCALIZED TO AXONS AND REGULATED IN DISTINCT POOLS 
 
III.1. Rationale and Summary 
The last decade has seen mounting interest in characterizing the localized mRNA content 
of neuronal axons and understanding its purposes for being there (Willis, van Niekerk et al. 
2007, Taylor, Berchtold et al. 2009, Zivraj, Tung et al. 2010, Gumy, Yeo et al. 2011, Baleriola, 
Walker et al. 2014, Minis, Dahary et al. 2014). As RNA biology continues to mature, it becomes 
increasingly imperative to unravel the complex web of regulatory interactions between mRNA 
transcripts, RNA-binding proteins, and organizing structures throughout the cell, particularly 
within specific subcellular compartments. Fortunately, this effort is just beginning to bear its first 
fruits, with the discovery of regulatory hubs that integrate the localization and translation of 
mRNAs (Tcherkezian, Brittis et al. 2010, Preitner, Quan et al. 2014). 
In the work presented here, an unbiased review of evidence for axonally localized 
transcripts of the microtubule motors and their related proteins was used as a starting place in 
order to investigate specific candidate mRNAs in greater depth. After verifying that two mRNAs 
coding for the dynein cofactors Lis1 and p150
Glued
 are localized to axons, their multilevel 





a. Transcripts for dynein and dynein cofactors, especially Lis1 and p150
Glued
, localize to axons 
It was evident, from reviewing the available literature, that the presence of mRNAs 
related to the function and regulation of the microtubule motors is a feature found 
repeatedly in axons of both the central and peripheral nervous system [FIGURE 3-A] (Gumy, 
Yeo et al. 2011, Baleriola, Walker et al. 2014, Minis, Dahary et al. 2014). Several members of 
the kinesin superfamily with recognized functions in axons are seen to possess axonally localized 
mRNAs, though this may vary widely among different species and neuronal subtypes. Likewise, 
transcripts for multiple subunits of cytoplasmic dynein 1 itself, including many of the heavy, 
intermediate, and light intermediate chains—essentially the core of the holoenzyme—appear to 
be localized to axons. By way of comparison, transcripts encoding equivalent subunits of 
cytoplasmic dynein 2, which is specific to intraflagellar transport (Pazour, Dickert et al. 1999), 
are not detected in axons with any consistency. Of the various cofactors associated with 
cytoplasmic dynein’s activity, the ones whose transcripts were found to be localized to axons in 
the greatest abundance and with the most reproducibility are Lis1 and the p150
Glued
 and 
p50/dynamitin subunits of the dynactin complex. 
Because of their characterized roles in adapting the dynein motor for different modes of 
transport (McKenney, Weil et al. 2011), it was decided to focus attention on Lis1 and dynactin’s 
main functional subunit, p150
Glued
. The chief experimental platform for the studies described 
here involved culturing primary rat neurons in tripartite microfluidic chambers that allow fluidic 
isolation of distal axons from cell bodies and dendrites [see FIGURE 2-A] (Taylor, Blurton-
Jones et al. 2005, Hengst, Deglincerti et al. 2009). To verify the finding that transcripts for Lis1 
and p150
Glued
 are localized to axons, single-molecule FISH was utilized to directly visualize the 
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mRNAs, Pafah1b1 and Dctn1 respectively, within axons of embryonic DRG neurons. Both 
mRNAs were readily detectable in a punctate pattern in axons and with significantly higher 
intensity than that obtained with a Gfp control probe [FIGURE 3-B]. 
 
b. Neurotrophin signaling regulates axonal levels of mRNAs coding for Lis1 and p150
Glued
 
It was next considered whether changes in NT signaling regulate the axonal localization 
of Pafah1b1 and Dctn1 transcripts, as it has previously been observed, in regenerating adult 
DRG axons, that NTs can regulate the abundance of specific mRNAs through their anterograde 
recruitment from the cell body (Willis, van Niekerk et al. 2007). In addition to testing the effects 
of NGF stimulation (100 ng ml
-1
) on the axonal abundance of these transcripts, how axons 
respond to NGF withdrawal (0 ng ml
-1
) was also examined. A third NGF concentration (5 ng   
ml
-1
) was chosen as a baseline against which to compare any changes, as this concentration is 
low but sufficient to keep embryonic DRG neurons alive in culture. Accordingly, quantitative 
FISH was performed on axons kept at 5, 0, or 100 ng ml
-1
 NGF for 12 h [FIGURE 3-B], 
allowing enough time for mRNAs to be redistributed and reach a steady-state concentration in 
axons. Quantification revealed that neither Pafah1b1 nor Dctn1 mRNA was recruited in response 
to stimulation with NGF, but, conversely, NGF deprivation caused a significant increase 
in axonal Lis1 transcript levels [FIGURE 3-C]. The FISH signal was shown to be specific for 
the targeted mRNAs, given that transfection of axons with siRNAs targeting either transcript 
reduced the FISH signal to background levels. As an orthogonal approach to confirm the 
results of the FISH experiments, quantitative real-time RT-PCR was performed on RNA 
harvested from axonal compartments under the same conditions [FIGURE 3-D]. This axonal 
RT-PCR likewise demonstrated a significant increase in Pafah1b1 mRNA with NGF 
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deprivation, and it seemed to indicate, more clearly than FISH, a trend towards an increase in 
Dctn1 mRNA also when axons are kept without NGF, though this effect was not significant. 
 
c. Lis1 and p150
Glued
 transcripts undergo differential translational activation in response to NGF 
stimulation or withdrawal 
When axons were transfected with siRNAs targeting Pafah1b1 or Dctn1 mRNA, it was 
discerned that the efficacy of siRNA knockdown varied depending on what concentration of 
NGF was applied to axons [FIGURE 3-C]. In particular, it did not appear that either transcript 
could be knocked down under the baseline condition of 5 ng ml
-1
 NGF. RISC and the RNAi 
pathway were previously shown to be functional in developing axons (Hengst, Cox et al. 2006), 
and it is possible to selectively silence an mRNA in axons via local siRNA transfection without 
causing any decrease of the transcript’s abundance in cell bodies (Hengst, Deglincerti et al. 2009, 
Baleriola, Walker et al. 2014, Gracias, Shirkey-Son et al. 2014, Baleriola and Hengst 2015). 
Unpublished observations from several members of the Hengst laboratory have suggested, 
however, that the susceptibility of axonal transcripts to RNAi may be linked to their accessibility 
to the translation machinery. According to this premise, the FISH data would imply that 
Pafah1b1 mRNA is translated in the case of either NGF stimulation or withdrawal, whereas 
Dctn1 mRNA is only translated due to stimulation with NGF. The consequences of this apparent 
differential translational regulation for Lis1 or p150
Glued
 synthesis within axons will be revisited 
and explored further in the succeeding chapter. 
The possibility that Lis1 transcripts might be translated as a specific response to 
withdrawal of NGF is curious, considering that translational regulation by NT signaling has, 
before now, only been described as a result of NT stimulation rather than deprivation (Cox, 
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Hengst et al. 2008, Hengst, Deglincerti et al. 2009, Andreassi, Zimmermann et al. 2010, 
Melemedjian, Asiedu et al. 2010, Gracias, Shirkey-Son et al. 2014). This prompted an 
investigation of translational activity in NGF-deprived axons, which was assayed by performing 
immunofluorescence against two translation markers, the phosphorylated forms of 4E-BP1 and 
S6 [FIGURE 3-E]. 4E-BP1 functions as a translational repressor by binding to eIF4E, the rate-
limiting component of the translational pre-initiation complex, but its phosphorylation forces it 
to dissociate from eIF4E and thus enables binding of mRNA to ribosomes (Haghighat, Mader et 
al. 1995). Meanwhile, S6 is a protein component of the 40S ribosomal subunit whose 
phosphorylation leads to increased translation (Thomas, Siegmann et al. 1980). While total 
staining for these markers was not significantly changed, phosphorylation of both was 
significantly increased upon withdrawal of NGF from distal axons within 10 min, a short time 
frame consistent with induction of translation by a local signaling pathway. It is known that the 
kinases that phosphorylate 4E-BP1 and S6 are both subject to activation by mTOR (Price, Grove 
et al. 1992, Hara, Yonezawa et al. 1997), so it was tested whether the application of rapamycin to 
axons would prevent the phosphorylation of these two proteins upon NGF withdrawal. Indeed, 
this treatment reversed the observed increases in 4E-BP1 and S6 phosphorlyation, indicating that 
translational activation upon NGF withdrawal is mTOR-dependent. 
 
d. Association with APC characterizes a distinct pool of axonal Lis1 transcripts 
Recently, Pafah1b1 was found to be part of the interactome of APC, a novel RNA-
binding protein (Preitner, Quan et al. 2014). APC is a microtubules plus-end tracking protein, 
also referred to as a “+TIP” (Nathke, Adams et al. 1996), and, by binding a specific cohort of 
mRNAs, it is proposed to be a regulatory platform for the localization and translation of 
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transcripts that are functionally important at the distal end of axonal microtubules. Consequently, 
it seemed pertinent to investigate whether association with APC was essential to Pafah1b1 
regulation in axons. To address this query, Pafah1b1-APC association was targeted using an 
LNA oligomer designed to bind and sterically block the putative APC binding site, a CUGU-
motif in the mRNA’s 3’UTR [see FIGURE 2-B]. A conceptually identical approach, utilizing a 
PNA instead of an LNA, was previously shown to be able to obstruct APC’s interaction with one 
of its target mRNAs (Preitner, Quan et al. 2014). A second LNA, binding Pafah1b1 mRNA 13 
bases upstream of the CUGU LNA, was designed for use as a control. The LNAs were 
transfected into the cell body compartment, and mRNA levels in axons were determined by 
quantitative FISH 12 h after different NGF treatments (5, 0, or 100 ng ml
-1
), as before [FIGURE 
3-F]. The control LNA had no discernible effect when compared to naïve axons (two-way 
ANOVA p=0.7585), while transfection with the CUGU LNA caused a reduction in 
axonal Pafah1b1 levels in all three conditions (p=0.008). The differences in Pafah1b1 mRNA 
abundance at 5 and 0 ng ml
-1
 or 0 and 100 ng ml
-1
 NGF were significant in both naïve and 
CUGU LNA-transfected axons and extremely similar in magnitude (5 and 0 ng ml
-
1
: 0.56 vs. 0.50; 0 and 100 ng ml
-1
: 0.58 vs. 0.68). These results suggest that interaction with 
APC may be responsible for the axonal localization of a fixed amount of Pafah1b1 but that the 






FIGURE 3-A: Transcripts encoding microtubule motors as well as their regulatory cofactors 
have been found in transcriptomes derived from embryonic rat DRG axons using microarray, 
embryonic mouse DRG axons using RNA sequencing, and embryonic rat hippocampal axons 
using RNA sequencing. Transcripts seen to be localized in all three studies are highlighted in 
red; Lis1 and p150
Glued

































































































































































































































































































































































































































FIGURE 3-D: DRG neurons were cultured in microfluidic chambers for 3 DIV, at which 
time the NGF concentration in the axonal chamber was changed to 5 ng ml
-1
. 24 h later, axons 
were treated with 0, 5, or 100 ng ml
-1
 NGF for 12 h, and then axonal RNA was harvested. 
Pafah1b1 and Dctn1 levels were determined by quantitative real time RT-PCR. Relative 
quantification with Gapdh as reference was done using the 2
-∆∆CT
 method. The means of the 5 
ng ml
-1
 NGF conditions for Pafah1b1 and Dctn1 were defined as 1.0. Data represent the 




































































































































































































































































































































































































































































































The fact that developing axons seem to be conspicuously enriched for mRNAs encoding 
microtubule motors and their associated proteins has been noticed before (Gumy, Yeo et al. 
2011), although, as of yet, no one has put forward any hypotheses or additional data as to why 
this might be. The fact that several kinesin transcripts are localized to axons is not particularly 
surprising given the multitude of different isoforms, and, while their localization is certainly 
interesting, it does not appear likely that investigating their presence would lead to any real 
conceptual breakthrough. On the other hand, the potential local translation of mRNAs coding for 
cytoplasmic dynein and its cofactors opens up physiologic and regulatory possibilities that 
previously could not be conceived. According to our current understanding, in order to function 
as a minus end-directed motor in axons dynein must, itself, be transported into the periphery as a 
cargo by kinesins (Ligon, Tokito et al. 2004). Of course, this arrangement poses several 
problems, chief among which is the issue of how the cell can control, at great distances from the 
soma, dynein’s switch from a cargo to an active motor when it is needed. Given the presence of 
transcripts for essentially all of dynein’s major components in the available axonal 
transcriptomes, one plausible solution, perhaps, is that the entire dynein motor could be locally 
produced de novo as needed. However, this approach would lead to another difficulty, namely 
the issue of stoichiometry and ensuring that all the necessary subunits are produced in equal 
proportions at the same time and place in order to assemble functional motor complexes. 
Moreover, newly synthesized dynein would somehow have to be recruited to the cargo in need of 
transport. Admittedly, given the availability of the various dynein transcripts, it is a distinct 
possibility that the axon does have mechanisms to provide for stoichiometric assembly of dynein 
complexes and their linkage to cargo. One would be hard-pressed, otherwise, to explain why 
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mRNAs encoding dynein subunits are localized to axons at all, if not to be locally translated. By 
comparison, though, the prospect of axonal synthesis of dynein’s cofactors from localized 
transcripts does not necessitate as many contingent factors. New Lis1 or p150
Glued
, made in 
axons as a response to a given stimulus, could be produced alongside new motors, or they could 
act as the triggers needed to convert preexisting, inactive dynein complexes into motors ready for 
transport. 
Indeed, in essentially all reported instances, localized translation has been seen to be 
stimulus-dependent. The finding that NGF withdrawal triggers translational activation within 10 
min leads to the question as to how the absence of a ligand can be a stimulus for downstream 
signaling. The extremely short time needed to induce translation rules out that it might be a 
consequence of neuronal degeneration caused by the lack of trophic support. Rather, 
translation appears to be triggered by a signaling pathway that is active in the absence of NGF 
and suppressed by NGF binding to TrkA. As noted previously, TrkA has been proposed to act as 
a dependence receptor, generating different signals in the absence of NTs as compared to when it 
binds ligand (Nikoletopoulou, Lickert et al. 2010, Dekkers, Nikoletopoulou et al. 2013). The 
same hypothesis might explain why persistent recruitment of Pafah1b1 and Dctn1 mRNA to 
axons is seen only in the NGF deprivation condition. It is possible that Trk receptor activation 
results in immediate downstream signaling, but, with time, the cell adjusts to a new set point and 
any effects of NT surplus no longer endure. Surveillance of axonal mRNA 12 h after NGF 
stimulation, as performed here, might not catch an earlier surge in Pafah1b1 or Dctn1 transcripts 
that has, by the time of observation, faded away. In contrast, an immature DRG neuron cannot 
simply adjust or become tolerant to starvation from NGF, especially if, as the dependence 
receptor model implies, TrkA signaling occurs chiefly in just such an absence of ligand. This 
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study, therefore, lends additional support to the dependence receptor hypothesis of TrkA 
function, and, further, an experimental paradigm is provided here with which to dissect the 
underlying pathway downstream of this receptor. 
The effects of LNA treatment blocking the putative Pafah1b1 APC binding site, 
including the finding that APC might bind a specific subset of axonal Pafah1b1 mRNAs, adds 
depth to previous observations of APC-dependent transcript localization. In the study initially 
identifying APC’s function as an RBP, a similar intervention using a nucleic acid analogue to 
hinder APC binding to β2B-tubulin transcripts was seen to dramatically reduce that mRNA’s 
localization to axons (Preitner, Quan et al. 2014). Some mRNA coding for β2B-tubulin 
continued to be detectable in axons, but this easily could have been attributed to incomplete 
efficacy of the PNA oligomer at blocking APC association. This previous study did not use any 
stimulus conditions in an attempt to regulate β2B-tubulin transcript recruitment to axons, 
however. As such, the evidence that a subtotal but defined amount of Lis1 transcripts is 
prevented from entering axons by disrupting their interaction with APC would indicate that the 
regulation of axonal mRNA localization is multifactorial. That is, APC is likely not the exclusive 
determinant of localization, even for its target mRNA species. 
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CHAPTER IV. LOCAL SYNTHESIS OF DYNEIN COFACTORS MATCHES 
RETROGRADE TRANSPORT TO ACUTELY CHANGING DEMANDS 
 
IV.1. Rationale and Summary 
Intra-axonal protein synthesis is crucial for axon development (Campbell and Holt 2001, 
Wu, Hengst et al. 2005, Hengst, Deglincerti et al. 2009, Gracias, Shirkey-Son et al. 2014), 
maintenance (Yoon, Jung et al. 2012), synapse formation (Taylor, Wu et al. 2013), and axon-to-
soma communication (Cox, Hengst et al. 2008), as well as for axonal regeneration (Rishal and 
Fainzilber 2014) and neurodegeneration (Baleriola, Walker et al. 2014). Axonal synthesis of Lis1 
itself has been demonstrated previously, but only in the context of retrograde transport of viral 
particles during neurotropic infection (Koyuncu, Perlman et al. 2013). From these 
investigations, a picture emerges in which local protein synthesis provides short-lived and 
spatially precise bursts of acutely needed proteins, in order to react to extracellular cues, 
injurious insults, or other changes in the axon’s environment. 
These studies sought to ascertain whether local synthesis of dynein cofactors could be a 
mechanism to acutely match axonal retrograde transport capabilities to changes in demand, as, 
for example, in response to changes in extracellular trophic support. As a result, it was 
discovered that intra-axonal synthesis of Lis1 and p150
Glued
 is required for the adjustment of 




a. NGF signaling regulates retrograde transport in a protein synthesis-dependent manner 
To investigate whether changes in axoplasmic transport are mediated through localized 
protein synthesis, embryonic rat DRG neurons were grown in microfluidic devices, and the 
effect of NGF stimulation or withdrawal on the transport of vesicular cargoes was assessed 
through live-imaging. Isolated axons were exposed to  different NGF concentrations (5, 0, or 100 
ng ml
-1
)  along with LysoTracker, a cell-permeable dye labeling late endosomes and 
lysosomes, in the presence or absence of pharmacologic inhibitors of protein synthesis, and the 
directional motility of LysoTracker-positive vesicles was appraised [FIGURE 4-A]. With either 
NGF stimulation or withdrawal, retrograde transport of large, LysoTracker-positive vesicles was 
significantly increased within 15 min, and a corresponding decrease was noted in 
the proportion of stationary vesicles [FIGURE 4-B]. The percentages of anterogradely or 
bidirectionally moving particles were not significantly changed with either NGF 
concentration. Inhibition of protein synthesis, however, completely abolished the increases in 
retrograde transport and significantly reduced anterograde transport upon NGF stimulation as 
well as NGF withdrawal. These results establish that axonal stimulation with NGF or withdrawal 
of NGF from axons both increase retrograde transport of large vesicular cargoes in a protein 
synthesis-dependent manner. 
 
b. Lis1 and p150
Glued
 are locally synthesized but differentially regulated in response to changes 
in axonal NGF signaling 
The presence of Lis1 and p150
Glued
 transcripts in axons raised the possibility that some of 
the observed changes in axoplasmic transport could be mediated through local synthesis of these 
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cofactors. As a first step, it was necessary to prove that newly made Lis1 and p150
Glued
 protein is 
synthesized in axons prior to or contemporaneous with the rapidly occurring changes in 
transport. Using quantitative immunofluorescence, the axonal abundance of Lis1 protein was 
found to be significantly increased upon either NGF stimulation or withdrawal for just 
10 min [FIGURE 4-C], while, in contrast, p150
Glued
 levels were elevated only in response 
to NGF stimulation [FIGURE 4-D]. These findings are consistent with prior inferences about 
the translational states of Pafah1b1 or Dctn1 mRNAs under these conditions, as presented in 
Chapter III. Levels of each protein were not changed by pre-incubation with protein synthesis 
inhibitors at the 5 ng ml
-1
 NGF baseline condition, but the increases in their abundance seen 
upon NGF stimulation (Lis1 and p150
Glued
) or withdrawal (Lis1 only) were eliminated 
when anisomycin or emetine were applied to the axonal compartment. 
As a more specific intervention to test whether local synthesis of Lis1 and p150
Glued
 is 
triggered by changes in axonal NGF signaling, axons were selectively transfected with siRNAs 
against the Pafah1b1 or Dctn1 mRNAs, or with a non-targeting control siRNA, prior to 
subjecting them to the three experimental NGF concentrations. For either protein, no significant 
reduction in abundance was detected in axons kept at 5 ng ml
-1
 NGF, once more indicating that, 
under this condition,  the transcripts are not locally translated to produce protein [FIGURES 4-E 
& 4-F]. Conversely, the significant increases in Lis1 abundance seen to result from NGF 
stimulation or withdrawal were totally abolished by local siRNA application, as was any increase 
in p150
Glued
 levels in NGF-stimulated axons. Taken together, these results demonstrate that, 
under certain conditions, axons have the ability to produce either Lis1 or p150
Glued
, but local 




c. Locally produced Lis1 is required for NGF-induced retrograde transport of large cargoes 
To determine whether the local synthesis of Lis1 and p150
Glued
 induced by changes in 
NGF signaling was capable of altering retrograde transport in axons, axons were incubated with 
LysoTracker, and the motility of labeled vesicles was scored, as described previously. Axonal 
knockdown of Pafah1b1 or Dctn1 did not significantly affect retrograde transport in the 5 ng ml
-1
 
NGF condition [FIGURES 4-G & 4-H], in line with the finding that neither protein is locally 
synthesized at this baseline condition. Axon-specific knockdown of Pafah1b1 abolished the 
significant increase in retrogradely moving LysoTracker-positive particles instigated by NGF 
withdrawal, while, in the NGF-stimulated condition, knockdown caused a reduction in the 
proportion of retrograde cargoes below even the baseline levels. In contrast, knockdown of 
axonal Dctn1 mRNA did not affect the movement of these large vesicular cargoes upon either 
NGF stimulation or withdrawal. These results establish that locally synthesized Lis1 is required 
for induced retrograde movement of large axonal cargoes, but p150
Glued
 is not. This conclusion is 
reminiscent of the finding that, with regard to their global synthesis, Lis1, but not p150
Glued
, is 
essential for high-load retrograde transport (Yi, Ori-McKenney et al. 2011). 
 
d. Transport of NGF-signaling endosomes requires local synthesis of Lis1 and p150
Glued
 
To investigate whether the requirement for local synthesis of dynein cofactor varied 
between differently sized cargoes, the retrograde transport of smaller NGF-containing 
signaling endosomes was also visualized (Delcroix, Valletta et al. 2003). Upon binding of NGF 
to its main functional receptor, TrkA, the receptor-ligand complex is internalized, and the 
resulting endosome is transported along with other downstream effector complexes to the 
soma by a dynein-dynactin complex (Zweifel, Kuruvilla et al. 2005). Mouse 2.5S NGF was 
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conjugated to fluorescent quantum dots (Cui, Wu et al. 2007), selectively applied to axons (100 
ng ml
-1
), and movement of QD-labeled NGF signaling endosomes was measured by live-cell 
microscopy [FIGURE 4-I]. The proportion of retrogradely moving particles seen under naïve 
and control siRNA conditions (~27%) was consistent with previous studies (Ure and Campenot 
1997, Echarte, Bruno et al. 2007). Axon-specific knockdown of Pafah1b1 or Dctn1 significantly 
reduced the retrograde movement of QD-positive particles and increased the proportion of 
stationary particles. It thus appears that the stimulated transport of different cargoes—
particularly those distinguished by size—may require the local synthesis of different regulator or 
adaptor proteins. 
 
e. Retrograde transport of a death signal in NGF-deprived axons requires local synthesis of Lis1 
Retrograde trafficking of NT signaling endosomes from axons to the cell body is widely 
considered to be required for the survival of neurons dependent upon target-derived neurotrophic 
support (Ye, Kuruvilla et al. 2003, Zweifel, Kuruvilla et al. 2005). Because of the observed 
reduction in retrogradely moving, QD-labeled NGF signaling endosomes upon axon-specific 
knockdown of Pafah1b1 or Dctn1 mRNAs [FIGURE 4-I], it was conceivable that survival of 
the DRG neurons might be impaired. To test this, cell death and survival assays were performed 
where NGF was withheld from the somatic and axonal compartments or applied (100 ng ml
-1
) 
to the axonal compartments only. In compartments where NGF was removed, a neutralizing anti-
NGF antibody was added to quench any residual NGF activity. Contrary to what was anticipated, 
axonal knockdown of either Pafah1b1 or Dctn1 in the NGF-replete condition did not 
induce apoptosis, as assessed by counting TUNEL-positive, dysmorphic nuclei, nor reduce the 
number of living neurons stained by calcein AM [FIGURES 4-J & 4-K]. Moreover, in the 
71 
 
NGF-starved condition, knockdown of Pafah1b1 had the unexpected effect of completely 
preventing NGF deprivation-induced cell death. Attempted knockdown of Dctn1 in the NGF 
deprivation condition did not impact cell death, consistent with the finding that NGF withdrawal 
does not actually lead to local synthesis of p150
Glued
  [see FIGURES 4-D & 4-F]. 
Remarkably, it thus appears that, although inhibition of local Lis1 and p150
Glued
 synthesis 
greatly impairs retrograde transport of NGF-containing signaling endosomes, their local 
production is not required for NGF-dependent survival. Instead, these findings are in support of 
an alternative explanation for the pro-survival activity of NGF, wherein it inhibits an axon-
derived, retrograde pro-apoptotic signal of as-yet-undetermined identity (Mok, Lund et al. 2009, 
Perlson, Maday et al. 2010). Furthermore, the results of the cell death and survival assays 
establish that intra-axonal synthesis of Lis1 is required for the generation or propagation of this 
death signal. 
 
f. Retrogradely transported GSK3β is the death signal triggered by axonal NGF withdrawal  
The known requirement of Lis1 for the transport of large cargoes with greater drag 
forces (Yi, Ori-McKenney et al. 2011) led us to ask whether the elusive retrograde death signal 
was of organellar size, perhaps a type of vesicle derived from endocytosis. To test this 
hypothesis,  the dynamin inhibitor dynasore was used to prevent endocytosis (Macia, Ehrlich et 
al. 2006). Application of dynasore specifically to axons completely inhibited cell death due to 
NGF deprivation, but it did not increase cell death in the NGF-replete condition [FIGURE 4-L]. 
For further characterization of the retrograde death pathway, attention was turned to protein 
kinases that have been implicated in apoptotic cell death in neurons. Whole-cell treatment with 
inhibitors of MLKs or p38 MAPKs has previously been shown to prevent neuronal apoptosis 
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induced by NT deprivation (Kummer, Rao et al. 1997, Harris, Deshmukh et al. 2002), but, in this 
experimental paradigm, application of these inhibitors to axons alone did not have the same 
effect, suggesting that these kinases act centrally rather than in the periphery. When two 
GSK3 inhibitors, LiCl or SB216763 (Stambolic, Ruel et al. 1996, Coghlan, Culbert et al. 2000), 
were applied selectively to axons, however, the induction of apoptosis with NGF deprivation was 
completely prevented, while neither inhibitor had any effect on cell death under NGF-replete 
conditions [FIGURE 4-L]. GSK3β previously had been proposed as a carrier of an axonally 
generated apoptotic signal (Mok, Lund et al. 2009). Jointly, these results indicate that the death 
signal, whose transport requires local Lis1 production, is likely an endocytic structure containing 
active GSK3β, such as an MVB (Dobrowolski and De Robertis 2012). 
 
g. Locally translated Lis1 transcripts from APC-dependent or APC-independent pools  fulfill 
distinct functions 
The finding that a single mRNA species, Pafah1b1, is locally translated in response to 
both NGF stimulation and withdrawal, and further—as we saw in the preceding chapter—is 
recruited into axons only upon NGF deprivation but not stimulation, strongly suggested the 
existence of regulatory mechanisms that control Pafah1b1 localization and translation under 
different signaling conditions. This raised the question of how interference with Pafah1b1-APC 
binding using the specially designed LNA oligomer would affect Lis1 protein abundance in 
axons, considering its previously seen effects at the level of transcript localization. To this end, 
cultured DRG neurons were transfected with the LNAs, as before, and quantitative 
immunofluorescence against Lis1 was performed after exposing the axons to different NGF 





 NGF, again confirming that it is not locally synthesized under this condition [see FIGURES 
4-C & 4-E]. The increase in axonal Lis1 abundance in CUGU LNA transfected DRGs at 0 ng 
ml
-1
 was indistinguishable from naïve and control LNA neurons, while, in NGF-stimulated 
axons, transfection with the CUGU LNA prevented the increase in Lis1 levels. Finally, the 
requirement of Pafah1b1-APC association for stimulation-induced retrograde transport of 
LysoTracker-positive cargos was investigated [FIGURE 4-N]. Transfection of the CUGU LNA 
had no effect on transport at 5 or 0 ng ml
-1
 but completely prevented the increase in retrograde 
transport triggered by NGF stimulation. 
Taken as a whole, the results from the LNA experiments reveal the existence of two 
distinct modes of Pafah1b1 localization in axons: one that is constitutively active and APC-
dependent, and another that is APC-independent and particularly responsive to NGF deprivation. 
The transcripts that are localized in the APC-dependent mode are translated in response to 
stimulation with NGF, while the APC-independent pool is locally translated with NGF 
withdrawal and is boosted by recruitment into NGF-starved axons. Thus, the two diametrically 
opposed triggers of axonal Lis1 synthesis, NGF withdrawal and stimulation, act on two separate 
pools of Pafah1b1 mRNA that each are solely responsible for the increase in local Lis1 levels 































































































































































































































FIGURE 4-B: Quantification of vesicular motility analysis in axons treated with protein 
synthesis inhibitors [see FIGURE 4-A]. LysoTracker-positive particles with diameters ≥1 μm 
were scored as anterograde, retrograde, bidirectional, or stationary. Data represent the means 
± SEM of 9 fields per conditions (n = 3 biological replicates). *p≤0.05; **p≤0.01; 








































































































































































































































































































































































































FIGURE 4-E: DRG neurons were cultured in microfluidic chambers for 3 DIV, at which 
point the NGF concentration in the axonal chamber was changed to 5 ng ml
-1
, and axons were 
selectively transfected with a non-targeting control siRNA or siRNAs targeting Pafah1b1. 24 
h after transfection, axons were treated with 0, 5, or 100 ng ml
-1
 NGF for 10 min, and axonal 
Lis1 levels were determined by immunofluorescence. Data represent the means ± SEM of 20-
75 optical fields per conditions (n = 4-15 biological replicates). *p≤0.05; **p≤0.01; 




FIGURE 4-F: DRG neurons were cultured and prepared for transfection as in FIGURE 4-E, 
and, on DIV 3, axons were selectively transfected with a non-targeting control siRNA or 
siRNAs targeting Dctn1. 24 h after transfection, axons were treated with 0, 5, or 100 ng ml
-1
 
NGF for 10 min, and axonal p150
Glued
 levels were determined by immunofluorescence. Data 
represent the means ± SEM of 20-40 optical fields per conditions (n = 4-8 biological 
replicates). ***p≤0.001. Two-way ANOVA with Dunnett’s multiple comparison test. Scale 


























































































































































































































FIGURE 4-H: Quantification of vesicular motility analysis in axons treated with siRNAs 
against Pafah1b1 or Dctn1 [see FIGURE 4-G]. LysoTracker-positive particles with 
diameters ≥1 μm were scored as anterograde, retrograde, bidirectional, or stationary. Data 
represent the means ± SEM of 12-18 fields per conditions (n = 4-6 biological replicates). 





FIGURE 4-I: DRG neurons were cultured in microfluidic chambers for 3 DIV, at which 
point the NGF concentration in the axonal chamber was changed to 5 ng ml
-1
, and axons were 
selectively transfected with a non-targeting control siRNA or siRNAs targeting Pafah1b1 or 
Dctn1. On DIV 4, axons were treated with 100 ng ml
-1
 QD-NGF for 15 min and live-imaged. 
Live-imaging time-lapse series of axonal fields were acquired, with images being taken every 
13 s for 4 min. QD-labeled particles <1 μm diameter were scored as anterograde, retrograde, 
bidirectional, or stationary. Means ± SEM of 9 optical fields per conditions (n = 3 biological 




FIGURE 4-J: After growing DRG neurons in microfluidic chambers for 3 DIV, the NGF 
concentration in the axonal chamber was changed to 5 ng ml
-1
, and axons were selectively 
transfected with a non-targeting control siRNA or siRNAs targeting Pafah1b1 or Dctn1. On 
DIV 4, the medium in the somatic compartment was changed to NGF-free medium containing 
NGF-neutralizing antibody, and axonal compartments were changed to either 100 ng ml
-1 
NGF or NGF-free medium with NGF-neutralizing antibody plus vehicle for 24 h. Cell death 
was assessed by TUNEL assay. Data represent the means ± SEM of 15-25 optical fields per 
conditions (n = 3-5 biological replicates). ***p≤0.001. Two-way ANOVA with Dunnett’s 




FIGURE 4-K: DRG neurons were cultured and transfected with siRNAs as in FIGURE 4-J. 
On DIV 4, the medium in the somatic compartment was changed to NGF-free medium 
containing NGF-neutralizing antibody, and axonal compartments were changed to either 100 
ng ml
-1 
NGF or NGF-free medium with NGF-neutralizing antibody plus vehicle for 24 h. 
Survival was assessed by calcein AM staining. Data represent the means ± SEM of 15 optical 
fields per conditions (n = 3 biological replicates). ***p≤0.001. Two-way ANOVA with 




FIGURE 4-L: After growing DRG neurons in microfluidic chambers for 3 DIV, the NGF 
concentration in the axonal chamber was changed to 5 ng ml
-1
. On DIV 4, the medium in the 
somatic compartment was changed to NGF-free medium containing NGF-neutralizing 
antibody, and the medium in the axonal chamber was changed to 100 ng ml
-1
 NGF or NGF-
free medium with NGF-neutralizing antibody plus the indicated inhibitors or vehicle for 24 h. 
Cell death was assessed by TUNEL assay. Means ± SEM of 15-25 optical fields per 
conditions (n = 3-5 biological replicates). ***p≤0.001. Two-way ANOVA with Dunnett’s 
















































































































































































































FIGURE 4-N: On DIV 3 of culturing DRG neurons in microfluidic chambers, the NGF 
concentration in the axonal chamber was changed to 5 ng ml
-1
, and cell bodies were 
selectively transfected with the control or CUGU LNAs. 24 h after transfection, axons were 
treated with 0, 5, or 100 ng ml
-1
 NGF together with LysoTracker Green for 15 min. Live-
imaging time-lapse series of axonal fields were acquired, with images being taken every 13 s 
for 4 min. LysoTracker-positive particles with diameters ≥1 μm were scored as anterograde, 
retrograde, bidirectional, or stationary. Data represent the means ± SEM of 9 optical fields per 
conditions (n = 3 biological replicates). *p≤0.05; **p≤0.01. Two-way ANOVA with 




Association with various accessory proteins enables cytoplasmic dynein to fulfill a 
multitude of cellular functions and to transport a wide variety of different cargoes (Vallee, 
McKenney et al. 2012, Maday, Twelvetrees et al. 2014). In these studies, evidence is provided 
that, within distal axons, dynein is regulated through local synthesis of Lis1 and p150
Glued
 in 
response to changes in local NGF signaling. The unidirectional nature of microtubules in 
axons poses special challenges for the acute regulation and initiation of dynein-dependent 
transport, and local translation of its adaptor proteins can solve this problem. As the 
unidirectional orientation of microtubules is not unique to axons but also occurs in distal 
dendrites (Baas, Deitch et al. 1988) or during neuronal cell migration (Rakic, Knyihar-Csillik et 
al. 1996), it is possible that such a mechanism is utilized in these circumstances, as well. 
Meanwhile, local synthesis of motor complex proteins is unlikely to be restricted 
to Lis1 and p150
Glued
. The effect on transport observed with protein synthesis inhibitors is more 
severe than with axon-specific knockdown of the two transcripts individually. Notably, 
anterograde transport of LysoTracker-positive vesicles in axons appears to be dependent on 
local protein synthesis even under baseline conditions, indicating that kinesins might also be 
regulated by local translation. Further, p150
Glued
 is only one of eleven subunits of dynactin. The 
transcript for another subunit, p50/dynamitin, is also consistently found in axonal transcriptomes, 
while the localization of transcripts coding for other subunits is less clear. It remains unknown 
whether the entire dynactin complex can be locally synthesized or whether it locally assembles 
with on-demand synthesis of p150
Glued
 and, potentially, p50/dynamitin.  
Thoughtful consideration of the evidence concerning axonal protein synthesis makes it 
clear that locally produced protein does not merely supplement the bulk synthesis of protein that 
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occurs in the cell body. Rather, locally synthesized protein is normally made to meet a specific, 
emergent need, and this same pattern appears to hold true for the dynein cofactors that have been 
studied here. For instance, neuron-wide knockdown of Lis1 has been seen to reduce retrograde 
axonal transport of LysoTracker-positive vesicles without the need for any stimulus condition 
(Pandey and Smith 2011), while the present studies found that axon-specific knockdown 
of Lis1 or p150
Glued
 could only prevent stimulation-induced changes in transport. Why is it that 
stimulated changes in transport require localized synthesis of new proteins, when constitutive or 
ongoing transport apparently does not? One possible explanation might be that, in response to 
environmental stimuli, previously inactive dynein motor complexes get activated and coupled to 
cargoes. In this regard, it is especially interesting that axonal Lis1 synthesis induced by NGF 
stimulation was found to require the association of Pafah1b1 mRNA with APC. As a +TIP, APC 
is ideally situated to mediate the activation of the dynein motor through local production of its 
regulatory proteins. In fact, the recruitment of dynactin by +TIPs has been found to be 
required for the initiation of retrograde axonal transport of various cargoes (Moughamian, 
Osborn et al. 2013). In Aspergillus nidulans, the Lis1 homologue has also been described as an 
initiation factor for dynein-mediated transport that is be absent from and unnecessary for dynein-
cargo complexes once they are in motion (Egan, Tan et al. 2012). Local synthesis of Lis1 or 
p150
Glued
 at precise loci in axons or growth cones could therefore act as a tuning or initiation 
mechanism for dynein-based transport. 
Contrary to expectations, it was seen that neither a reduction of NGF signaling 
endosome transport towards the cell body nor the inhibition of endocytosis in axons caused cell 
death of DRG neurons. These results are in stark contrast to the proposed signaling endosome 
mechanism of NTs’ effects, in which internalization and retrograde transport of ligand-receptor 
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complexes is requisite. On the other hand, these findings are in accordance with an alternative 
theory explaining the action of NTs, in which NGF, for example, promotes survival by locally 
suppressing an intrinsic death pathway originating in axons (Mok, Lund et al. 2009) without the 
need for trafficking of NGF or TrkA from axons to cell bodies (MacInnis and Campenot 2002, 
MacInnis, Senger et al. 2003, Mok and Campenot 2007). If neurotrophic signaling endosomes 
truly are not responsible for carrying pro-survival signals from the axon to the cell body, as was 
assumed, then their functional significance is difficult to explain and may require thorough 
reexamination in order to understand. 
The present finding that association with APC establishes distinct pools of axonally 
localized Pafah1b1 mRNA that differ as to whether they are translated in response to NGF 
stimulation or withdrawal provides mechanistic insight into the differential regulation of 
axonally localized mRNAs. In addition to regulating localization, APC acts as a “translational 
hub” for its associated mRNAs, spatially orchestrating protein synthesis in axons and growth 
cones (Preitner, Quan et al. 2014). It remains unknown how many translational hubs might exist 
in axons, or where they are to be found. A recent report that the netrin receptor, DCC, 
binds components of the protein synthesis machinery and regulates local 
translation (Tcherkezian, Brittis et al. 2010) suggests that APC is certainly not unique.  
In conclusion, through these studies, a mechanistic explanation is provided for how a 
unidirectional motor can be tuned to fulfill changing transport needs far away from the cell body, 
and it is further revealed that, within subcellular compartments like axons, transcripts of the same 




CHAPTER V. EVIDENCE FOR AXONALLY SYNTHESIZED DYNEIN COFACTORS 
CONTRIBUTING TO AMYLOID-INDUCED NEURODEGENERATION 
 
V.1. Rationale and Summary 
Ongoing research seeks to illuminate the mysterious etiology and pathogenetic processes 
of AD, but it has not escaped notice that several of the hallmarks of early disease progression 
involve microtubule-based transport. Disorganization of the tubulin cytoskeleton due to 
hyperphosphorylated tau aggregation along with frank deficits in organelle trafficking are among 
the earliest manifestations of AD pathology (Ebneth, Godemann et al. 1998, Ishihara, Hong et al. 
1999, Stokin, Lillo et al. 2005), and, intriguingly, these problems first begin to appear not in 
somata or dendrites but in axons (Iqbal, Liu et al. 2009, Perlson, Maday et al. 2010). Recent 
work has also implicated localized protein synthesis as an essential early step in the axonal 
response to Aβ (Baleriola, Walker et al. 2014), the neurotoxic peptide that aggregates in AD’s 
characteristic neuritic plaques. 
Accordingly, the possibility was considered that AD-associated deficits in axonal 
transport might involve changes in intra-axonal synthesis of dynein cofactors, similar to what we 
have observed in the case of developing axons’ responsiveness to NTs. In model systems of 
amyloidopathy, it was found that Aβ exerts a complex and dynamic effect on axonal transport, 
which seems likely to be correlated with the peptide’s regulation of the axonal localization and 




a. Local application of amyloid-β oligomers induces recruitment of Lis1 transcripts into 
hippocampal axons  
Previous work has established that exposing cultured hippocampal axons to oligomers of 
the Aβ1-42 peptide triggers the recruitment into the axonal transcriptome of a specific cohort of 
mRNAs (Baleriola, Walker et al. 2014). Indications from RNA-sequencing suggested that 
Pafah1b1 may be among the mRNAs regulated by Aβ1-42, so FISH was performed on axons 
exposed to Aβ1-42 or DMSO vehicle for 24 h in order to confirm [FIGURE 5-A]. Quantification 
of this data showed that Pafah1b1 abundance was robustly increased 24 h after Aβ1-42 
application, as compared to treatment with the vehicle control. This recruitment effect was 
apparent in either naïve or control siRNA-transfected axons but was prevented by axonal 
transfection with siRNAs specifically targeting Pafah1b1 mRNA, which resulted in FISH signal 
comparable to the vehicle-treated control axons. Meanwhile, within the DMSO condition, there 
were no significant differences between naïve axons or axons transfected with a control siRNA 
or even the Pafah1b1-targeting siRNAs. 
 
b. Axonal synthesis of Lis1 shuts down in the short term after amyloid-β exposure 
Given Aβ’s evident effect stimulating the localization of Lis1-encoding transcripts to 
hippocampal axons, the question arose as to whether this neurotoxic peptide also regulated 
axonal Lis1 transcripts at the level of translation. By quantitative immunofluorescence, it was 
observed that, compared to vehicle-treated conditions, Lis1 protein abundance tended to be lower 
in distal axons treated for 24 h with Aβ1-42 oligomers, although this trend was not significant 
[FIGURE 5-B]. Moreover, axon-specific transfection of siRNAs against Pafah1b1 was not 
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effective at reducing Lis1 levels any further in the Aβ-treated condition, even though these 
siRNAs did significantly decrease axonal Lis1, as compared to the naïve and control siRNA-
transfected samples, in the DMSO-treated condition. While these results indicate that, under the 
conditions described here, pervasive local synthesis of Lis1 occurs in axons of cultured 
hippocampal neurons, the inefficacy of RNAi at least within the first day after Aβ exposure 
suggests, based on what we have seen before, that this condition leads to a suspension of axonal 
Pafah1b1 translation concomitant with inaccessibility to RISC. 
 
c. Chronic amyloid-β exposure has a biphasic effect on axonal transport 
To determine whether axonal siRNA-mediated silencing of Pafah1b1 or Aβ’s similar 
effect in reducing Lis1 produced changes in retrograde transport in axons, the transport assay 
used extensively in previous work, involving the incubation of axons with LysoTracker and 
scoring the motility of labeled lysosomes and late endosomes, was employed once more. In the 
vehicle-treated condition, where it was previously seen that application of Pafah1b1-targeting 
siRNAs significantly decreases Lis1 in axons, the present attempts at Lis1 knockdown yielded 
only a modest reduction in retrogradely moving particles and corresponding increase in 
stationary particles [FIGURE 5-C]. An equally mild effect was seen in Aβ1-42-treated axons 
transfected with Pafah1b1-targeting siRNAs. However, besides the decrease in retrograde 
particles with axonal Pafah1b1 knockdown compared to naïve samples in the DMSO condition, 
none of these results featured statistically significant differences. 
As a gauge of retrograde axoplasmic transport of such cargoes in vivo, FluoroGold, a 
fluorescent tracer that accumulates in lysosomes (Persson and Havton 2009), was co-injected 
along with DMSO or oligomeric Aβ1-42 into the dentate gyrus of living mice [see FIGURE 2-C]. 
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The dentate gyrus contains axons and synaptic terminals of certain cholinergic neurons residing 
in septal nuclei of the basal forebrain (Amaral and Kurz 1985, Leranth and Frotscher 1989), so 
the number of FluoroGold-labeled neurons found in the basal forebrain at given points in time 
after injection into the dentate gyrus was taken as a readout of retrograde lysosome flux. At 2 
days post injection, there was a slight paucity of FluoroGold-positive basal forebrain neurons in 
the Aβ-treated condition relative to the vehicle control [FIGURE 5-D], suggesting a transport 
deficit in line with the in vitro results presented here and previous studies showing that short-
term Aβ exposure rapidly inhibits axonal transport (Hiruma, Katakura et al. 2003, Pigino, 
Morfini et al. 2009). Nonetheless, by 4 days post injection, this trend had reversed, with more 
FluoroGold-positive cells actually found in the Aβ-treated condition; the situation at 7 days post 
injection showed an even wider gap, as FluoroGold labeling in the basal forebrains of Aβ-treated 
animals continued to increase relative to what was seen in vehicle-treated cases. Taken together, 
these findings strongly indicate that unalleviated exposure of axons to Aβ oligomers causes long-
term induction of retrograde vesicular trafficking, after an initial period of inhibiting transport. 
 
d. Axonally produced Lis1 regulates multiple cell death and survival pathways in cultured 
hippocampal neurons 
Finally, it seemed pertinent to examine whether the regulation of retrograde transport by 
intra-axonal synthesis of Lis1 might be involved in neuronal survival or apoptosis pathways, as 
seen in the case of DRG neurons. Thus, TUNEL assays were performed on cultured hippocampal 
neurons whose axons were incubated with Aβ1-42 or vehicle for 48 h, and which were previously 
transfected with Pafah1b1-targeting or control siRNAs or left untransfected. As would be 
expected, exposure to Aβ1-42 caused a significant increase in the number of apoptotic cells 
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detected in naïve or control siRNA-transfected axons [FIGURE 5-E]. Interestingly, axonal 
knockdown of Pafah1b1 was sufficient to prevent this Aβ-induced cell death. However, in stark 
contrast, transfection with Pafah1b1-targeting siRNAs in the DMSO-treated condition was itself 
the cause of significantly greater cell death than was observed in controls. The seeming 
contradiction of axonal Lis1 knockdown leading to apoptosis in one circumstance while 
preventing it in another would appear to indicate that several distinct pathways governing 




FIGURE 5-A: Hippocampal neurons were cultured in microfluidic chambers. On DIV 8, 
axons were selectively transfected with a non-targeting control siRNA or siRNAs targeting 
Pafah1b1. On DIV 9, axons were treated with vehicle or Aβ1-42 oligomers for 24 h. Axonal 
Pafah1b1 mRNA levels were evaluated by FISH. Data represent the means ± SEM of 10-15 
optical fields per conditions (n = 2-3 biological replicates). *p≤0.05. Two-way ANOVA. 




FIGURE 5-B: After growing hippocampal neurons in microfluidic chambers for 8 DIV, 
axons were selectively transfected with a non-targeting control siRNA or siRNAs targeting 
Pafah1b1. On DIV 9, axons were treated with vehicle or Aβ1-42 oligomers for 24 h. Axonal 
Lis1 protein levels were then measured by quantitative immunofluorescence. Data represent 
the means ± SEM of 25-40 optical fields per conditions (n = 5-8 biological replicates). 




FIGURE 5-C: On DIV 8 of culturing hippocampal neurons in microfluidic chambers, axons 
were selectively transfected with a non-targeting control siRNA or siRNAs targeting 
Pafah1b1. On DIV 9, axons were treated with vehicle or Aβ1-42 oligomers for 24 h. On DIV 
10, axons were supplied with LysoTracker Green for 15 min and live-imaging time-lapse 
series of axonal fields were acquired, with images being taken every 13 s for 4 min. 
LysoTracker-positive particles with diameters ≥1 μm were scored as anterograde, retrograde, 
bidirectional, or stationary. Data represent the means ± SEM of 12 optical fields per condition 


















































































































































































































































FIGURE 5-E: Hippocampal neurons were cultured in microfluidic chambers for 8 DIV, at 
which point axons were selectively transfected with a non-targeting control siRNA or siRNAs 
targeting Pafah1b1. On DIV 9, axons were treated with vehicle or Aβ1-42 oligomers for 48 h. 
Cell death was assessed by TUNEL assay. Means ± SEM of 50-60 optical fields per 
conditions (n = 5-6 biological replicates). *p≤0.05. Two-way ANOVA with Dunnett’s 




 The immediate-early signaling pathways activated in axons by exposure to extracellular 
Aβ are very poorly understood. Several Aβ-binding sites on the plasma membrane have been 
identified, but their involvement in mediating Aβ neurotoxicity has been difficult to establish 
conclusively. For example, although Aβ is known to interact with p75
NTR
, whether this binding is 
toxic or protective in nature is disputed (Perini, Della-Bianca et al. 2002, Zhang, Hong et al. 
2003). Similarly, the low density lipoprotein, NMDA, and α7 nicotinic acetylcholine receptors 
have all been reported to be involved in Aβ internalization into neurons (LaFerla, Troncoso et al. 
1997, Bi, Gall et al. 2002, Nagele, D’Andrea et al. 2002), and yet what second messengers or 
downstream effectors are involved in the response to either intracellular or extracellular Aβ 
remains largely a mystery. Attention has been drawn sequentially to reactive oxygen species 
(Behl, Davis et al. 1994), nitric oxide (Vodovotz, Lucia et al. 1996), and calcium release from 
the endoplasmic reticulum (Suen, Lin et al. 2003), without a clear picture emerging as to what 
effects of Aβ are attributable to which pathway, if any, of those studied. 
 It is important to recognize this relative paucity of knowledge, as it has shaped the design 
and interpretation of the experiments utilized here. While the results of these experiments are 
undoubtedly informative, much of the information they provide is, in a sense, pending better 
understanding of the pathophysiologic effects of Aβ in order to be evaluated with complete 
clarity. The chief stumbling block put forward by the present data lies in the apparent 
discrepancy between Aβ’s effects on Lis1 at the levels of transcript localization and translation in 
axons. Whereas Pafah1b1 mRNA appears to be recruited to axons en masse within one day of 
their incubation with Aβ, all indications from Lis1 immunofluorescence and in vitro vesicular 
transport assays are that, within this timeframe, these transcripts are not being translated to 
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generate protein. Despite this being somewhat counterintuitive, it may prove to be extremely 
revealing. Since the initial discovery that Aβ oligomers are potently toxic to neurons, researchers 
have speculated that the progression of AD could be shaped by the “biphasic impact of Aβ-
derived diffusible ligands acting upon particular neural signal transduction pathways” (Lambert, 
Barlow et al. 1998). Lacking any information about the signaling pathways in question, it was 
still natural to infer that Aβ must have a biphasic effect, because, even as Aβ begins to 
accumulate, neuronal death is not at all characteristic of AD pathology until its later stages 
(Bredesen, Rao et al. 2006). Remarkably, we have now seen this kind of biphasic effect as it 
pertains to retrograde axonal transport, which is inhibited in the short-term by exposure to Aβ 
oligomers but, based on the in vivo FluoroGold tracing, later appears to undergo a major 
induction, at least with regard to degradative cargoes like lysosomes. Therefore, a simple 
explanation for the results we previously found to be incongruous might be that, by conducting 
our observations after one day of exposure to Aβ, we are catching the tail end of Aβ’s inhibitory 
effect on axoplasmic transport, even as the axon is stocking itself with Lis1 transcripts and other 
apparatus for the transport induction phase to follow. Indeed, through the cell death assays, 
where neurons were incubated with Aβ for a longer time, we can begin to see an effect of 
siRNA-mediated knockdown in the Aβ-treated condition, implying that Lis1 transcripts are being 
locally translated. 
 The fact that intra-axonal synthesis of Lis1 seemed to be detected here in vehicle-treated 
axons of cultured hippocampal neurons and could be effectively targeted by RNAi poses another 
problem. As a reminder, in practically every circumstance in which localized protein synthesis 
has been described, it has been in response to a specific stimulus or change. It may be that 
growing hippocampal axons, in contrast, more or less constitutively require locally synthesized 
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Lis1, or, potentially, something about the utilized culture conditions, such as the laminin coating 
of the substrate, provided an unrecognized stimulus for local synthesis of this protein. However, 
it is also conceivable that the relatively long period that the neurons were kept in culture—and, 
especially, in a compartmentalized culture situation—might have led them to become stressed, 
and this stress enabled local synthesis of certain proteins as a response. The length of keeping 
neurons in culture was dictated by the time that it took for their axons to grow past both sets of 
microgroove barriers in the tripartite microfluidic chambers used for experiments, and this took 
significantly longer for hippocampal neurons than for the DRG neurons employed in preceding 
chapters. 
Although valuable information was certainly gleaned from these studies in cultured 
hippocampal neurons, if the experiments were to be redesigned and attempted again it might be 
beneficial to use bipartite microfluidic devices instead, so that axons could be isolated and tested 
more quickly. Of course, it would also be interesting to expand the investigation beyond Lis1, as 
dynactin subunits may very well have their own part to play in modulating axonal transport in 
response to extracellular Aβ. 
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CHAPTER VI. SIGNIFICANCE AND CONCLUSIONS 
 
VI.1. Conceptual Significance 
a. Coordinate control of mRNA localization and translation 
It has been proposed that functionally related cohorts of mRNAs bound to particular 
RBPs could represent “post-transcriptional operons,” analogous in purpose to the polycistronic 
genetic regulatory structures seen in prokaryotes (Keene and Tenenbaum 2002). Recent work on 
the interactome of APC has provided an example lending credibility to this model (Preitner, 
Quan et al. 2014), and the studies presented here have shown that, in the case of Pafah1b1 
mRNA found in axons, association with APC facilitates the localization and translation of a 
subpopulation of this transcript species that has a situation-specific functional relevance. 
Blocking the interaction between APC and Pafah1b1 reduces the mRNA’s abundance in axons 
by only a fraction, but removal of this APC-dependent fraction of Pafah1b1 completely prevents 
certain stimulus-induced transport effects that rely upon axonal synthesis of Lis1 protein. 
Although the potential for a single mRNA species to be packaged into multiple different RNPs 
had been noticed previously, before now it was difficult to demonstrate that distinct functional 
consequences were attributable to subsets of transcripts distinguished by their associated RBPs. 
Interestingly, the cases of both Pafah1b1 and Dctn1 mRNA show that the regulation of transcript 
localization and translation do not necessarily go hand-in-hand. Even if both processes are 
controlled by association with a single RBP, a transcript might not be translated under a 
condition where it is recruited into axons, or vice versa. Explaining why this might be would 
require further investigation, but, based on what we have seen so far, it may indicate a difference 
between the acute and chronic responses to a given stimulus. 
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b. Motor regulation throughout subcellular compartments 
Through these studies, a previously unrecognized mechanism has been uncovered for 
acute tuning of the dynein motor via localized synthesis of its regulatory cofactors. While we 
have focused on dynein motor control in axons as a model system, the findings of the present 
research may be generalizable to subcellular locales throughout different kinds of cells. 
Cytoplasmic dynein together with dynactin and Lis1 are known to localize to the leading cell 
cortex of directionally migrating cells, where their inhibition leads to impaired cell movement 
(Dujardin, Barnhart et al. 2003). At the same time, several mRNAs essential to cell migration 
have been seen to localize to and undergo local translation at the leading edge (Shestakova, 
Singer et al. 2001, Willett, Brocard et al. 2013, Maizels, Oberman et al. 2015), perhaps hinting 
that the same might occur for dynein and its cofactors. Such findings make it clear that localized 
expression of protein takes place in cells far less morphologically complex than neurons. 
Considering the established importance of dynein’s interaction with Lis1 for the 
development and patterning of the cerebral cortex, it might be fruitful to explore whether Lis1’s 
roles in radial glia and migrating cortical neuron progenitors involve localized synthesis of the 
protein. It has been observed that the lissencephaly phenotype classically associated with Lis1 
haploinsufficiency is enhanced by mutation of APC (Hebbar, Guillotte et al. 2008), and 
conditional knockout of APC in neural progenitor cells actually results in severely disrupted 
cortical lamination on its own (Yokota, Kim et al. 2009). As opposed to global Lis1 abundance, 
the recruitment of transcripts encoding Lis1 specifically to microtubule plus-ends and their local 
expression there might thus be a critical but as yet unappreciated step in normal cortical 
migration, which, when disrupted, produces the devastating effects of lissencephaly. 
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Finally, these results might help to resolve a considerable point of argument about several 
dynein cofactors, concerning their role in the initiation of dynein-driven transport. This 
controversy has proven especially problematic for Lis1, which appears to produce physical 
effects on the motor that imply its persisting attachment (McKenney, Vershinin et al. 2010, 
Huang, Roberts et al. 2012) yet is found, by some groups, to only be necessary when initiating 
the motor’s activity from a standstill (Egan, Tan et al. 2012). The results presented here may 
offer a sort of compromise, wherein stimulus-induced, intra-axonal synthesis of dynein cofactors 
is specifically responsible for the observed effects on initiation of transport for certain cargoes. 
 
c. A “retrosome” for axon-to-soma signaling 
On the basis of the findings that NGF deprivation-induced cell death depends upon a 
retrograde signaling complex produced through endocytosis and requiring GSK3 activation, it 
was postulated that this death signal might be a GSK3β-containing endosome or MVB. It has 
long been appreciated that MVBs represent a sizable portion of retrogradely transported cargoes 
in vivo (Tsukita and Ishikawa 1980), and GSK3 sequestration into MVBs has been reported to 
take place in other cell signaling pathways (Taelman, Dobrowolski et al. 2010). Interestingly, 
Weible and Hendry, two of the originators of the signaling endosome hypothesis of NT function, 
previously proposed that MVBs, by enclosing and preserving a representative sampling of 
signaling molecules from the axon prior to transport, could “allow the cell body to receive a 
snapshot of the events occurring” in the periphery (Weible and Hendry 2004). Accordingly, they 
dubbed the MVBs seen in axons “retrosomes.” It seems that the results are very consistent with 
this idea of retrosomes as a constitutive signaling platform for axon-to-soma communication. 
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VI.2. Technical Applications 
a. Approaches to localized translational profiling 
By informing us as to what proteins can be produced locally versus those which must be 
trafficked from the cell body, subcellular transcriptomes have proven to be an indispensable 
resource in uncovering the various roles of localized protein synthesis. Yet, as we have seen, not 
all of the transcripts that are present in a subcellular locale like the axon will be undergoing 
translation at the same point in time or in a given situation. In some cases, what we really wish to 
know is which localized mRNAs are actively associated with polyribosomes and being translated 
under the circumstances that we are studying. Methods for gathering this information about the 
“translatome”—such as the extension of RNA sequencing into what is known as ribosome 
profiling, or Ribo-Seq—are just beginning to be applied to whole cells (Ingolia, Ghaemmaghami 
et al. 2009, Ingolia, Lareau et al. 2011, Brar, Yassour et al. 2012). Notably, there is already 
interest building in applying these kinds of techniques to subcellular compartments, especially in 
neurons (Kitchen, Rozowsky et al. 2014), but, thus far, there has been little in the way of 
concrete results (Kratz, Beguin et al. 2014). 
In this respect, the finding that the ability to silence axonally localized mRNA through 
RNAi may be tied to the translation state of the transcripts in question presents an unexpected 
methodological opportunity. RNA sequencing is relatively difficult and time-consuming, and 
preparing RNA, particularly from isolated axons, requires a tremendous amount of biological 
material. However, this observation implies that a western blot or immunostaining of an axonal 
protein of interest after local siRNA treatment could be a valid approach to determining whether 
the mRNA coding for that protein is being actively translated. That is, if axonal knockdown is 
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seen to be effective in reducing the protein’s abundance, the result indicates that the protein is 
being translated. 
Contrary to the findings presented here and the hypothetical approach just expounded, it 
is worth pointing out that RNAi is conventionally understood not to be coupled by necessity to 
translation (Gu and Rossi 2005). In whole Drosophila embryo lysates, for instance, the 
application of protein synthesis inhibitors was not seen to perturb efficient RNAi (Zamore, 
Tuschl et al. 2000). Nevertheless, components of RISC, which is the molecular machinery for 
RNAi, have repeatedly been found to associate with ribosomal proteins and RNAs (Hammond, 
Boettcher et al. 2001, Caudy, Ketting et al. 2003, Pham, Pellino et al. 2004), as well as with 
whole polyribosomes (Djikeng, Shi et al. 2003). The purpose of this association between RISC 
and ribosomes is not presently understood, but it is conceivable that what is true for RNAi 
globally might not be so in subcellular compartments like axons. The unique RNP packaging and 
regulatory systems that control mRNA localization and expression in these compartments might 
mean that specially localized mRNAs are generally less accessible than their cell body 
counterparts to both RISC and ribosomes. Accordingly, since each process requires mRNAs to 
become accessible to their respective machinery, localized translation and RNAi would be 
correlated even if not mechanistically linked. 
 
b. Targeting localized protein synthesis in vivo 
A long-standing criticism of research into localized protein synthesis has involved the 
doubt as to whether this phenomenon is actually relevant to biological systems at work in living 
tissues and organisms, or if it is just an unphysiologic artefact of cells in culture. While in vivo 
demonstrations have been provided for the functions of a few locally synthesized proteins, such 
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as importin β1 in axonal injury signaling (Perry, Doron-Mandel et al. 2012) or β-actin in 
supporting axon regeneration after injury (Donnelly, Willis et al. 2011), in many other cases the 
methods needed to generate such proof presently do not exist. Not long ago, two colleagues 
eloquently summarized the distinctive challenge of devising interventions to target localized 
protein synthesis, saying, “Conclusive evidence in support of an in vivo physiological role for 
local translation ideally requires some way of selectively perturbing translation in a subcellular 
compartment of interest while not affecting production of the same gene product elsewhere in the 
cell” (emphasis added, Perry and Fainzilber 2014). Most of the pharmacological or molecular 
biological tools sufficient for work in vitro, with the aid of compartmentalized culture techniques 
and the like, cannot manage such selectivity in vivo. Provided that anatomy conveniently affords 
a spatial separation between the somata of the neurons of interest and their projecting axons, an 
inhibitor compound or siRNA could be applied locally in the region of the axons, but this 
approach cannot absolutely rule out that any resulting effects are due to the involvement of glia 
or other neurons surrounding those axons. 
For β-actin and importin β1, selective perturbation of their synthesis in axons was made 
possible by exceptionally detailed knowledge about the mechanisms of their mRNA localization. 
Preventing β-actin mRNA’s binding to the RBP responsible for its localization or genetically 
deleting the preferentially localized long 3’ UTR isoform of importin β1 mRNA produced, in 
either case, what amounted to a subcellular knockdown (Donnelly, Willis et al. 2011, Perry, 
Doron-Mandel et al. 2012). Of course, this is precisely what the APC-blocking LNA oligomer 
has already been employed to do in vitro, with the added qualification that it appears to target 
only a functional subfraction of axonal Lis1 transcripts. Applying this LNA or others like it for 
use in vivo will be more or less trivial. In utero electroporation techniques have been used 
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effectively for some time to introduce molecular biological reagents to the central nervous 
systems of mammalian embryos, which would be a prime setting in which to utilize LNAs for 
interfering with mRNA localization and local translation events (Tabata and Nakajima 2001, 
Takahashi, Sato et al. 2002). Because such LNAs would selectively block the targeted 
transcripts’ localization to axons or another subcellular compartment as desired, there should be 
less potential for off-target effects, and the delivery system for the reagent need not distinguish 
between neurons and glia or other surrounding cells that do not share neuronal morphology. The 
tantalizing prospect of being able to finely dissect out different cellular roles for a single protein 
through methods of function-specific inhibition thus appears to be just entering our grasp. 
Moreover, the applicability of these tools to in vivo studies represents an extraordinary 
opportunity for future research into localized protein synthesis and cell biology in general. 
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VI.3. Future Directions 
a. Follow-up studies 
In order to validate that the effects of the CUGU LNA treatment are, in fact, due to 
inhibited binding of APC to the Lis1 transcript, several additional experiments are necessary. To 
begin with, the physical interaction between APC and this particular mRNA should be proven 
more directly, beyond relying upon the apparent APC binding motif in the mRNA’s 3’ UTR. 
One well-established method is to use ultraviolet light to crosslink RNAs with their interacting 
RBPs in situ, then perform immunoprecipitation for the protein of interest—in this case, APC. 
RNA that is pulled down with APC can be purified from the protein and analyzed by RT-PCR to 
see if it contains Pafah1b1 transcripts. The inverse approach, of pulling down Pafah1b1 mRNA 
to detect what RBPs associate with it, has also been made possible quite recently by the 
exploitation of nuclease-deficient Cas9 protein, which can be targeted to Pafah1b1 by a specific 
guide RNA (Qi, Larson et al. 2013). Using this technique, which is currently being evaluated for 
this application by other members of the Hengst laboratory, has the distinct advantage of 
yielding information specific to Pafah1b1, and it could therefore reveal what other RBPs this 
transcript associates with, beyond merely confirming its binding to APC. After it is shown 
definitively that APC binds the transcript, it should be straightforward, using one of the two 
outlined techniques, to prove that application of the CUGU LNA reduces this association. 
Another line of inquiry that would be suitable to follow up on concerns the retrograde 
apoptotic signaling complex induced by NGF deprivation. Although it is parsimonious to infer 
that endocytosis and GSK3 activation are both involved in the generation of the same signal, 
strictly speaking this cannot be deduced based on the data collected so far. It would strengthen 
our conclusion to visualize GSK3 within axons to ascertain whether this kinase localizes to any 
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particular type of endocytic compartment, which often can be distinguished on the basis of their 
morphology and characteristic Rab membrane proteins. Of course, it would be especially 
informative to see if GSK3’s localization bears any relation to that of Trk receptors, or if its 
localization changes along with its activation state given different conditions of NGF signaling. 
 
b. Neuronal maturation and the downregulation of axonal protein synthesis 
The observation that embryonic DRG neurons can be made insensitive to NGF 
deprivation simply by inhibiting axonal synthesis of Lis1 raises fundamental questions about the 
transient NT dependence of many developing neurons. Upon reflection, it is curious that intra-
axonal translation apparently undergoes quiescence over the course of neuronal maturation, in 
parallel to the neurons themselves becoming less dependent upon neurotrophic support. It could 
therefore be hypothesized that protein synthesis-dependent mechanisms within axons, such as the 
Lis1-mediated signaling pathway here identified, are what confer temporary dependence upon 
NTs to developing neurons. Previous work investigating the basis of neuronal maturation and NT 
independence has noted that TrkA receptors display more persistent phosphorylation in mature 
neurons, which endures even in the complete absence of NGF (Tsui-Pierchala and Ginty 1999). 
This would suggest that, as the neuron matures, TrkA is tuned to be less sensitive for 
distinguishing between NGF’s presence and absence, instead being set by default to the mode of 
signaling normally associated with its ligand-bound state. Having reached its innervation target 
and completed its morphological elaboration, it makes sense for the mature neuron to settle into a 
more maintenance-focused state, which involves re-tuning of its receptors for extrinsic signals 
and downregulation of the localized protein synthesis pathways that were appropriate for more 
dynamic circumstances where acute responses were constantly needed. Yet, if later on the axon 
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faces a dramatic change, such as physical injury or neurotoxic stress, it can reactivate its 
quiescent mechanisms of intra-axonal protein synthesis in order to mount a rapid and effective 
response. 
 
c. Differential post-translational modifications of locally synthesized proteins 
Although here it has been taken for granted that locally synthesized proteins should be 
molecularly identical to their cell body-produced counterparts and thus function mechanistically 
in the same way, it might not be true that axonally and somatically generated versions of the 
same protein would be entirely equivalent. Theoretically, it would seem practical for the cell to 
have means of distinguishing proteins based on where they were produced so that it can regulate 
their activity and lifespan appropriately. One feasible prospect for organizing such control is 
through differential post-translational modification of proteins depending on their point of 
origin—the application of a sort of “MADE IN SOMA” or “MADE IN AXON” label to the 
newly synthesized protein. Lis1 may prove to be an instructive case in this regard. The yeast 
homologue of Lis1 is a known target of SUMOylation (Alonso, D'Silva et al. 2012), and there 
are indications of late that this modification may be conserved in mammals (Alonso, Greenlee et 
al. 2015). While it is not exclusive to axons, covalent attachment of SUMO to proteins has 
already been shown to occur in axons and may preferentially mark proteins undergoing 
retrograde transport towards the cell body (van Niekerk, Willis et al. 2007). Given the already-
exploited ability to perform axon-specific knockdown of Lis1, it should be straightforward to 
determine through biochemical methods whether axonally synthesized Lis1 has a preferential 
disposition to be SUMOylated or not. 
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Even if there is no detectable difference between the fractions of axonally versus 
somatically derived Lis1 that are marked by SUMOylation, there is another conceivable scenario 
in which this modification could be particularly important to the regulation of axonally produced 
protein. Unlike the related ubiquitin modification, SUMO is not conventionally associated with 
marking proteins for degradation (Mahajan, Delphin et al. 1997), but SUMOylation can 
occasionally help to recruit specialized ubiquitin ligases and thus initiate ubiquitin-mediated 
proteolysis (Prudden, Pebernard et al. 2007). Only a few mammalian SUMO-targeted ubiquitin 
ligases have been identified thus far (Tatham, Geoffroy et al. 2008, Poulsen, Hansen et al. 2013), 
and, while at least one appears to be expressed in certain types of neurons (Kelly, Thymiakou et 
al. 2013), there is no indication that these enzymes are localized to axons. Lis1 protein produced 
in either somata or axons might therefore undergo SUMOylation, but axonal SUMO-Lis1 could 
be more stable due to the absence of SUMO-targeted ubiquitin ligases in axons. However, if 
SUMO-Lis1 were carried with motor-cargo complexes back to the cell body, it would then be 
subjected to ubiquitylation and consequent degradation. Of course, such a system remains 
speculative and might not be widely generalizable to different axonal proteins. Still, it is clear 
that, alongside transcript localization and local translation, post-translational modification and 
the control of protein lifespan merit further investigation as they pertain to the regulation of 
protein abundance and function within subcellular compartments. 
 
d. Beyond “local” translation: protein synthesis-dependent regulation at a hyperlocal scale 
Referring to protein synthesis as “localized” if it occurs somewhere within a subcellular 
compartment instead of the cell body has been convenient, but it is increasingly becoming 
obsolete. Axons, for instance, are often upwards of twenty times more voluminous than the cell 
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body itself (Daroff and Aminoff 2014), and, although “hot spots” for protein synthesis have been 
visualized within axons (Aronov, Aranda et al. 2002), it has been difficult to establish with 
certainty the distinguishing characteristics of these hot spots or what cellular substructures they 
represent. The discovery that APC mediates mRNA localization specifically to microtubule plus-
ends and the exploitation of this fact to selectively inhibit an apparent functional subfraction of 
locally produced protein may therefore represent the crossing of a significant threshold. We are 
encouraged by these findings to conceive of evermore-defined cellular landmarks, ranging from 
vesicles and organelles to the plasma membrane to cytoskeletal formations and more, as potential 
platforms for “hyperlocal” protein synthesis. Consistent with this perspective, a recent report has 
already implicated mitochondria in coordinating nearby protein synthesis machinery for active 
translation that is needed at sites of axon branch formation (Spillane, Ketschek et al. 2013). 
Probing hyperlocal translation could have a profound impact on our understanding of 
physiologic systems, including the intracellular transport regime that so much time has been 
devoted to considering here. The characterization of molecular motors fundamentally changed 
how we thought about motility in cells, and, for the most part, it drew our attention away from 
the cargoes themselves. However, the association of protein synthesis machinery with some 
cargoes might suggest that they can “hitch a ride” with dynein or kinesin motors, effectively 
regulating their own motility by locally synthesizing adaptor proteins on their surface. In the 
fungus Ustilago maydis, polyribosomes have been seen to be transported on the surface of early 
endosomes and are likely translationally active there (Higuchi, Ashwin et al. 2014), suggesting 
the real possibility of such a phenomenon. As our ability to detect and intervene in these kinds of 
hyperlocal processes improves, it seems quite likely that their study will become an increasingly 
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